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ABSTRACT

Bordetella bronchiseptica is a Gram-negative respiratory pathogen of a wide rang

of mammals. B. bronchiseptica infections are of key interest to the veterinary a
agricultural industries. Lipopolysaccharide (LPS) is the major component of the

outer cellular membrane and is hence integral to the implementation of many cell

processes throughout the life cycle. A genetic locus responsible for LPS core an
antigen biosynthesis in B. bronchiseptica has been recently identified. However
discovery of all the genes responsible for the production of the LPS inner core
thusfar evaded researchers. A novel genetic locus, encoding phosphoglucomutase
(PGM) is described here. The pgm gene of B. bronchiseptica is required for the
biosynthesis of the LPS inner core molecule. Genetic analysis of pgm identified

gene as approximately 1.2 kb in length that shares high amino acid identity with
PGM of various other bacterial species. The pgm gene forms part of an operon
which also encompasses the gene encoding phosphoglucose isomerase. B. pertussis

was also found to contain a homologous gene sharing 97% identity with that of B.

bronchiseptica. PGM is an enzyme responsible for the conversion of glucose to th

high energy nucleotide sugar, UDP-glucose, which is subsequently incorporated in
the LPS inner core, being only the second residue following the lipid Aketodeoxyoctulosonic acid (KDO) moiety. Insertion mutations of the wild type B.
bronchiseptica strain BB7865 and the bvg strain BB7866, which disrupted LPS
biosynthesis was created and characterised (BB7S65pgm and BB7S66pgm).

Functional assays for PGM revealed that enzyme activity is expressed in both bvg

positive and frvg-negative strains of B. bronchiseptica and is substantially red
BB7S65pgm and BB7866pgm. Silver stained tricine SDS PAGE analysis of purified

V

LPS from the mutants revealed a profile severely modified from that of the parenta
strains. Complementation of the mutated pgm gene with that from BB7865 restored
the wild type LPS phenotype. To test the invasive ability of these LPS deficient
strains, in vitro survival assays were performed with the J774.A1 mouse

macrophage-like cell line. The results of these assays demonstrated that the mutan

were significantly reduced in their ability to invade (2 h, 40% reduction) and sur
(24 h, 60% reduction) post-infection. Many other phenotypes were tested and shown

to be significantly altered by this mutation. One such phenotype is motility. Only

low levels of motility were achieved by either the 6vg-positive or the 6vg-negativ

mutant, indicating a possible role for LPS as an important "anchor" for the flagell

filament. The inability to produce wild type LPS also resulted in a reduced bacter

resistance to oxidative stress and a higher susceptibility to the antimicrobial pe
cecropin P. In contrast, the activities of two enzymes thought to play important
intracellular survival roles, ie. superoxide dismutase and acid phosphatase, were
unaffected in the PGM deficient strain, thereby implicating LPS as playing a
protective role during intracellular survival. Complementation of the mutated pgm
gene with pgm from BB7865 completely restored the wild type condition as to
resistance to oxidative stress and cecropin P, and invasion and survival within

J774.A1 cells in vitro. To investigate the role of LPS in pathogenesis, BB7865/?gm
was directly compared to the wild type strain BB7865, in its ability to cause
respiratory infection. BB7865/?gm was shown to be significantly attenuated in its

ability to survive in the murine respiratory tract following intranasal inoculatio
being effectively cleared from the lungs within 4 days. The wild type strain in

contrast was shown to persist for at least 35 days-post infection. These results f

first time not only determine a gene for inner core biosynthesis, but also demonst

VI

the importance of the lipopolysaccharide molecule in the virulence of B.
bronchiseptica.
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INTRODUCTION

1.1. The Genus Bordetella

Members of the Bordetellae Genus have long been acknowledged as being
responsible for respiratory diseases of mammals and birds. Seven species have been
characterised to date. The best known of these is Bordetella pertussis due to its
ability to infect humans. This species is the causative agent of whooping cough, a

severe and sometimes fatal disease of children. Other members of the Genus include
Bordetella parapertussis, Bordetella bronchiseptica, Bordetella avium, Bordetella
holmesii, Bordetella hinzii and Bordetella tremantum. Bordetella parapertussis
produces a milder whooping cough-like syndrome in humans that is less frequently
diagnosed (Musser et al., 1986). B. bronchiseptica has a broad host range, being
found to cause disease in nearly all non-human mammals. B. avium causes

respiratory infections in birds and is accredited as being the etiological agent o
turkey bordetellosis (Leyh and Griffith, 1992). B. holmesii has only recently been
detected and characterised from blood cultures of adult humans where it has been

associated with endocarditis, respiratory failure and septicemia (Tang et al, 1998;
Weyant et al, 1995). Like B. avium, B. hinzii is predominantly a pathogen of birds
but has been isolated from immuno-compromised human patients. Also isolated
from ear and wound infections of humans is B. tremantum (Vandamme et al., 1996),
however little is known of the biology of these last two species.

Several attempts have been made to determine and classify the relatedness of the
members of the Bordetella Genus. The most recent attempts have been based upon
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deoxyribonucleotide sequence relationships (Kloos et al., 1981), electrophoretic
allelic variation (Musser et al., 1986), pulse field electrophoresis of restriction
digests (Khattak and Mattewa, 1993) and 16S r R N A sequence similarity (Weyant et
al, 1995). This method of comparison demonstrated a > 9 8 % degree of homology
between B. pertussis, B. bronchiseptica, B. parapertussis, B. avium and B holmesii
(Figure 1.1) over 1525 nucleotide bases pairs. With this type of alignment, other
closely related species included Alcaligenes xylosoxidans, Alcaligenes faecalis and
Oxalobacterformigenes (> 9 0 % similar)(Weyant et al, 1995).

r B. holmesii
*" B. pertussis
r B. bronchiseptica
__

B. parapertussis

—— B. avium

Figure 1.1. Relatedness of the Bordetella Genus based on 16S rRNA alignment.

The primary focus of this thesis is the bacterium B. bronchiseptica. This species i
of importance to both the veterinary and agricultural industries. Interest in B.
bronchiseptica has steadily developed since the 1970's, following an increase in
animal and economic losses due to respiratory disease (Goodnow, 1980).

B.

bronchiseptica has been credited as being the principle effector of tracheobronchitis
in dogs from as early as 1910 (Ferry, 1910) and is k n o w n to be associated with
Pasteurella multocida in a c o m m o n , economically significant, bronchial affliction of
swine, ie. atrophic rhinitis (Chanter et al, 1989; Roop II et al, 1987). In dogs the
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infectious process is limited to the tracheobronchial tree and is characterised by
adherence and localisation of the pathogen to surface structures and cilia of the
respiratory epithelial cells (Woolfrey and Moody, 1991).

Atrophic rhinitis is a common respiratory disease of swine, which can result in
damage to the nasal turbinates and associated tissues. B. bronchiseptica has been

identified as the initial pathogen, causing damage to the turbinates by the action o
dermonecrotic toxin. It was first believed that B. bronchiseptica alone was the
causative agent of swine atrophic rhinitis (Nakai et al, 1988). It now is recognised
and widely accepted that atrophic rhinitis is a result of a mixed infection of B.
bronchiseptica and P. multocida. Considerable evidence indicates that P. multocida
is the major pathogenic agent, and B. bronchiseptica acts as a conditioning agent,
that plays an inducing role. Specifically, the local damage caused by the
dermonecrotic toxin of B. bronchiseptica is thought to enhance the growth of
toxigenic strains of P. multocida on the nasal turbinate (Ackermann et al, 1991;
Roop II et al, 1987; Woolfrey and Moody, 1991).

B. bronchiseptica has also been isolated from a diverse range of animals including
rabbits, monkeys, seals (Baker and Ross, 1992; Bemis et al, 1977; Graves, 1970),
and turkeys (Leyh and Griffith, 1992). However, this species of Bordetella has only
rarely been implicated as an infective agent in humans. Approximately 25 cases are
documented with the outcome of infection resulting in diseases such as pneumonia,
septicemia, acute maxillary sinusitis, paroxysmal cough, meningitis and whooping
cough. In all cases the patient was immunocompromised and/or had significant
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animal contact (Chang et al, 1975; Gueirard et al, 1995; Tamion et al, 1996;
Woolfrey and Moody, 1991).

B. bronchiseptica has been the subject of much research due to the significant DNA
homology and the similar bacteriological properties with B. pertussis. The two

species were at one stage being considered classified as a single species (Kloos et a
1981). Although this is not the case today it is widely accepted that information
gained about B. bronchiseptica can directly influence the understanding of B.
pertussis biology (Goodnow, 1980; Kloos et al, 1981).

The bacteriological characteristics of B. bronchiseptica are as follows. It is an
obligate aerobe that is Gram-negative, non-spore forming, pleomorphic and

coccobacillary in shape. It is positive in tests for motility, urease, catalase, oxid
citrate utilisation, nitrate reduction, and tetrazolium reduction. Negative results
however are found in tests for tyrosine hydrolysis, indole, acid production in
oxidation-fermentation of glucose and maltose media. Motility of the organism is
achieved by peritrichous flagella (Goodnow, 1980).

1.1.1. Infection and the requirement for phenotypic regulation

Bordetella species exhibit preferential adherence to human or animal ciliated
respiratory epithelial cells. In contrast to the preference of B. pertussis and B.

parapertussis for adherence to human ciliated cells, B. bronchiseptica preferentiall
adheres to non-human ciliated cells of mammals such as dogs, rabbits and mice. The
Genus Bordetella is unique in that the bacterium is able to multiply whilst still
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attached to the ciliated epithelium (Tuomanen et al, 1983). Bordetella species
provide a good example of an effective adherence mechanism as no other bacterial
respiratory pathogens are known to withstand clearance along the mucociliary
escalator (Tuomanen et al, 1983). It is well recognised that adherence is a
significant initial step in colonisation and infection.

It was widely accepted that B. bronchiseptica infection is non-invasive to the surfa

mucosa and is restricted to the ciliated epithelium, sparing the alveoli (Tuomanen et
al, 1983). Evidence now suggests that Bordetella species are not exclusively
extracellular pathogens but can in fact invade and survive in certain types of
eukaryotic cells, for example HeLa cells (Ewanowich et al, 1989a; Savelkoul et al,
1993), CHO, HEp-2 cells (Schipper et al, 1994), macrophages, polymorphonuclear
leukocytes and dendritic cells (Friedman et al, 1992; Guzman et al, 1994b; Guzman
et al, 1994a; Steed et al, 1991). A dramatic reduction in internalisation was
reported following the treatment of epithelial cells with cytochalasin D (a

microfilament inhibitor) indicating that receptor mediated endocytosis is the method
of internalisation. Unlike B. pertussis and B. parapertussis, the invasion by B.
bronchiseptica is not dependent on the expression of 6vg-activated genes (Banemann
and Gross, 1997; Savelkoul et al, 1993).

1.1.2 Antigenic Modulation

B. bronchiseptica may encounter environments during its life cycle that vary greatly
Whether this be during infection, transmission between hosts or survival in an
environmental niche outside a host, the bacteria must be capable of responding
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appropriately to these changes. In order to exploit these varying environments, B.
bronchiseptica is able to modify its phenotype in response to the prevailing
conditions to ensure the expression of an array of molecules suitable for that
environment. This process is referred to as antigenic or phenotypic modulation.
Phenotypic modulation is a freely reversible change in the phenotype of an entire
bacterial population. Phase variation on the other hand is a term used to explain
phenotypic changes that occur at frequencies greater than can be accounted for by

spontaneous mutation. Phase variation is a genetic, highly stable alteration and is
therefore distinct from phenotypic modulation (Peppier and Schrumpf, 1984).

A single genetic locus, known as the Bordetella virulence gene (bvg) locus (Weiss

and Falkow, 1984) is responsible for a signal transduction system that coordinately

regulates the expression of a number of virulence factors. Examples of such are the
adhesin filamentous haemaglutinin (Cotter et al, 1998), and the toxins, adenylate
cyclase haemolysin and dermonecrotic toxin (van den Akker, 1997; Walker and
Weiss, 1994). These virulence associated determinants are regulated in response to
environmental conditions such as temperature and chemical modulators, ie. sulfate
anions (Akerley et al, 1992; Lacey, 1960), and can usually be categorised into two
main phenotypic states, 6vg-activated (Bvg+) or 6vg-repressed (Bvg").

The bvg locus is a member of the so-called two component regulatory system family.
The two components of the Bordetella locus are the proteins Bvg A and BvgS, which

are encoded by 2 genes of the same name (Figure 1.2). This type of system is widely
distributed among bacterial Genera (Beier et al, 1995; Gross, 1993) and are

responsible for regulating processes as diverse as cell division, nitrogen fixation
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chemotaxis stress responses and virulence (Uhl and Miller, 1994). These systems are
not unique to prokaryotes as they have also been discovered in eukaryotic organisms
from the Genera of Arabidopsis and Saccharomyces (Chang et al, 1993; Ota and
Varshavsky, 1993). The typical mechanism employed by these systems for signal
transduction is one in which an environmental stimuli is translated from a sensor
protein (BvgS) to a transcriptional activator (BvgA).

Although not all mechanisms of the Bvg signal transduction system are completely
understood, there is little doubt as to the benefits of the accurate regulation of
individual phase factors. Expression of the bvg+ phase is required and sufficient for
persistent infection (Martinez de Tajada et al, 1998). However there is little

evidence that any virulence repressed genes (vrg) are ever utilised during the course
of an infection. There remains the capacity for phenotypic modulation however,
which indicates the possibility of a 6vg-repressed stage sometime during the life
cycle of the bacterium. Suggestions have been made that the system is only a
remnant and has been maintained simply due to the requirement of BvgA to activate
expression (Merkel et al, 1998a). It is probable that processes of the bvgAS locus
and the production of virulence determinants are intimately coordinated during
infection and that antigenic modulation may occur during colonisation. Bvgactivated genes are indeed critically required for infection but in comparison to B.
pertussis, 6vg-repressed genes are more defined in B. bronchiseptica. A bvgrepressed adhesin, which is expressed only by modulated bvg+ strains, has been
identified from virulent swine isolates, which may be involved in the initial
colonisation. Attachment to ciliated nasal epithelial cells, measured as number of

adherent bacteria per cell, was almost three times greater when the bacteria was firs
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cultured at 23°C. This O M P adhesin was shown not to be F H A or pertactin. This
highly adhesive phenotype was also shown to persist for 18 h following the
subsequent incubation of the bacterium at 37°C (Register and Ackermann, 1997). It

is conceivable that this frvg-repressed adhesion would play an important role in ear
colonisation of bacteria from a low temperature, modulating environment.

Two separate studies have demonstrated that avirulent B. bronchiseptica strains have
a significant long-term survival advantage over virulent strains (Banemann and
Gross, 1997; Schipper et al, 1994). Down regulation of vags following
internalisation is thought to be one way in which the bvg locus contributes to the
longevity of infection. A reduction in bvg+ associated toxins, which would otherwise

be cytotoxic to host cells, may ensure an intracellular environment favourable for B

bronchiseptica in terms of survival. In support of this theory is the discovery that
adenylate cyclase production is down-regulated following intracellular invasion
(Banemann and Gross, 1997).

It is also well established that while the frvg-activated phase is required for infe

the 6vg-repressed phase is advantageous for survival in nutrient limiting conditions
Incredibly, B. bronchiseptica has been shown to not only survive but also replicate
phosphate buffered saline, pond water, sea water and even reagent grade laboratory
water (Porter et al, 1991). Survival in these conditions is only possible in a bvg'
state. Further evidence for the necessity of Bvg regulation came from a study which

demonstrated that ectopic expression of flagella, a bvg' phase phenotype, in the bvg
phase resulted in reduced virulence (Akerley et al, 1995). It is clear that the
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regulation of virulence factors exerted by bvg is an essential part of infection in order
to maximise colonisation.

1.2. Bordetella Virulence Gene Locus (bvg)

It was first observed in 1910 that Bordetella pertussis expressed differing antigeni
profiles depending on the culture medium (Bordet and Sleeswyck, 1910). In 1960,
B. bronchiseptica and B. parapertussis were included in a study that showed these
bacteria could alternate between three phenotypic phases, ie. modes X, I and C
(Lacey, 1960).

It is now understood that the genetic regulator of such phenotypic changes is a signa
transduction system encoded by a single genetic locus, known as the Bordetella

virulence gene (bvg) locus (Stibitz et al, 1989). This locus has also been designated
vir, due to it being a mediator of virulence determinant regulation. A permanently
avirulent (frvg-negative) phenotype of B. bronchiseptica may arise due to small
deletions in the bvg locus (Monack et al, 1989).

Co-ordinate regulation of gene expression in response to environmental stimuli such
as temperature, sulfate anions, and nicotinic acid has been observed in B.
bronchiseptica (Akerley and Miller, 1993; Akerley et al, 1992; Beattie et al, 1992),

at least in vitro. Bordetella pathogenesis relies upon the secretion of a large arra
toxins and adhesion proteins (Table 1.1), which include filamentous haemaglutinin,
dermonecrotic toxin, adenylate cyclase-haemolysin and fimbriae to name a few
(Gueirard and Guiso, 1993; Tuomanen et al, 1983). The major toxin of B. pertussis,
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pertussis toxin is also included in this group (Arico and Rappuoli, 1987). These
virulence determinants arise as a result of a class of genes known as vz'r-activated
genes (vag) and are expressed when the growth conditions are non-modulating. This
can be induced in vitro at a growth temperature of 37°C, low sulfate concentration,
such as < lOmM MgS04, and/or < 0.2mM nicotinic acid. The organism is now said
to be in X mode or virulent phase. B. bronchiseptica will exist in C mode (avirulent
phase) at a lower growth temperature of 25°C and the presence of the chemical
modulators named above. This will lead to the induction of various vz'r-repressed
genes (vrg) such as those involved in flagella biosynthesis (Akerley et al, 1992;
West et al, 1997) and siderophore production (Giardina et al, 1995a).

The existence of such a regulatory system that responds to environmental stimuli and
controls virulence gene expression indicates that pathogenic bacteria regulate the
production of their virulence factors in a particular way in order to generate an

infection (Beattie et al, 1992). It also indicates that modulation operates to limit t
production of certain virulence factors when not required, thus avoiding what
otherwise would be an energetically expensive process. Also ectopic expression of
virulence factors is detrimental to effective colonisation. It has been demonstrated
that the frvg-activated phase is sufficient for infection; the expression of a bvgrepressed phenotype, when not required results in reduced virulence (Akerley et al,
1995)
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1.2.1. BvgS

BvgS is a 135 kDa transmembrane protein capable of sensing and responding to
environmental cues. The protein consists of four key domains, the periplasmic

sensor domain, the cytoplasmically located transmitter, the receiver, and C-term
domains (figure 1.3). The three cytoplasmic domains are connected to the sensor

Table 1.1. 5vg-regulated factors of the three main Bordetella species. Ability to express the gen
indicated by a dot (•). B. pertussis (B. per), B. parapertussis (B. par), and B. bronchiseptica (B. bro).

.Bvg-activated gene

B.per

B. par

B.bro

Adenylate cyclase-haemolysin

•

•

(Betsou et al, 1995)

Dermonecrotic toxin

•

•

(Pullinger et al, 1996)

Pertussis toxin

Reference

(Locht and Keith, 1986)

Tracheal cytotoxin

•

•

(Luker etal, 1995)

Filamentous haemaglutinin

•

•

(Relman et al, 1989)

Fimbriae

•

•

(Boschwitz et al, 1997)

Pertactin

•

•

(Li etal, 1992)

Tracheal colonisation factor

(Finn and Stevens, 1995)

Z?vg-repressed gene
Motility

•

(Akerley et al, 1992)

Acid phosphatase

•

•

(Chhatwal et al, 1997)

Siderophore

•

•

(Giardina et al, 1995b)

Vrg-6

{Beanie etal, 1990)

Vrg-\8

(Beattie etal, 1990)

Vrg-73

(Beattie etal, 1990)
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domain via a linker region of 159 amino acids. It is this linker region that when

mutated is responsible for locking BvgS in its active form (Miller et al, 1992; Stib
and Yang, 1991). The stimulus detected by BvgS is transferred across the cellular
membrane into a cellular signal by way of a phosphorylation cascade (Beier et al,
1995) across the BvgS cytoplasmic domains (Figure 1.3). The transmitter domain of
BvgS possesses kinase activity, which allows for autophosphorylation of the

transmitter at a conserved histidine residue (729). The phosphate is then transferred

to an aspartic acid residue (1023) of the receiver, which instigates a conformationa

change thereby affecting the activity of the output domain. A lysine located in clos
proximity to the terminal portion of the receiver seems crucial for this purpose
(Parkinson and Kofoid, 1992; Stock et al, 1989). The phosphate can now be relayed
to a region of the C-terminal output domain known as the histidine-1172

phosphotransfer region (Cotter and Miller, 1997). The presence of three domains, ie.
transmitter, receiver, and output, make this system one of the most complex in
regards to other two component regulatory systems (Beier et al, 1995).

The existence of the additional receiver domain of BvgS is not unique to Bordetellae
but has also been identified in Agrobacterium tumefaciens and Escherichia coli, in
proteins designated VirA and ArcB respectively. In these cases however the receiver

domain is not essential for signal transduction since deletion of this domain does n
alter the regulatory function of the system (Chang and Winans, 1992; Iuchi and Lin,
1992; Pazour et al, 1991). In contrast, deletion of the receiver domain of BvgS
resulted in a complete loss of vag factor expression (Beier et al, 1995).
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1.2.2. BvgA

BvgA is the second component, ie. the systems activator. BvgA is a 23 kDa
cytoplasmically located protein that is composed of two domains, a receiver and a Cterminal helix-turn-helix domain ( H T H ) (Arico et al, 1989; Stibitz and Yang, 1991).
A n aspartic acid residue at position 54 of the receiver will accept the phosphate from
the C-terminus of BvgS thereby completing the phosphorelay. The phosphorylated
BvgA, due to a conformational alteration, has an increased affinity for 6vg-activated
promoters (Steffen et al, 1996). Following phosphorylation, the H T H - D N A binding
motif is able to bind with specific D N A sequences and in turn lead to transcription
and hence direct control of various cellular processes (Beier et al, 1995; Finlay and
Falkow, 1997).

bvgA

bvgS

JL
RECEIVER/REGULATOR

SENSOR

TRANSMITTER RECEIVER

JL
CONSTANT
REGION

VARIABLE REGION

CONSTANT
REGION

Figure 1.2. A diagrammatic illustration of the bvg locus. The arrows indicate the coding region of
b v g A and bvgS. Various domains encoded by each are indicated at their relative positions below
arrows. The bvgS gene contains regions which encode hydrophobic transmembrane domains as
indicated by the regions in yellow (Arico et al, 1991).
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The receiver domains of both B v g S and B v g A are capable of dephosphorylating the
system by donating their phosphoryl groups to water (Cotter and Miller, 1997).
Several theories about the mode by which BvgA regulates gene expression have been

postulated. One theory stipulates that the receiver exhibits direct control over the
availability of the functional interface (DNA binding motif) to binding sites. This

occurs due to the conformation of the inactivated molecule "masking" the active site
Once the protein is phosphorylated (active conformation) the DNA-binding domain
is exposed and transcription of the required genes occurs. This is a well-accepted
scheme, accounting for the basics, and for simplicity is the premise illustrated in
Figure 1.3. A second theory involves the production of a phosphorylation-induced
dimer consisting of two BvgA molecules. Only as a dimer would BvgA show an

increase in binding affinity (Parkinson and Kofoid, 1992). More recently it has been
suggested that the actual mechanism is a combination of the two theories. This
hypothesis states that unphosphorylated BvgA monomers mask a dimerization
interface that is required for recognition between two BvgA molecules (Boucher et
al, 1994). Upon conformational alterations in the structure of the monomer, two
proteins may couple and greatly enhance binding potential for target promoters.
Whatever differences may exist between these hypotheses, the fundamental principle
stands, and that is BvgA is explicitly activated due to the phosphorelay cascade
brought about by BvgS in response to environmental stimuli.

The bvg locus of B. bronchiseptica and B. pertussis are nearly identical and are

functionally interchangeable. The bvgA genes of the two species are in fact identica
however 61 amino acid differences exist in regard to BvgS (1238 aa) (Martinez de
Tejada et al, 1996). To investigate possible variation of function between the
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systems from either origin, as a result of these differences, a chimeric strain of B.
bronchiseptica was produced which contained the B. pertussis bvgAS locus. The
ability of this mutant to express either bvg+ or bvg' specific factors was
indistinguishable from the wild type. There was however a dramatic difference in
sensitivity to modulating signals. Significantly more MgS04 or nicotinic acid was
needed to initiate modulation as compared to the wild type. This is likely to be due
to the fact that the majority of the amino acid alterations between the species (68%)
exist in the periplasmic sensor region. It is therefore now accepted that the
periplasmic region of BvgS is responsible for signal sensitivity (Martinez de Tejada
et al, 1996). Further evidence that the bvgAS loci of the two are functionally

interchangeable is that the chimeric strain demonstrated an indistinguishable ability
to cause respiratory tract infections in rats as that of the wild type.

The expression of bvgAS in E. coli has been shown to result in reduced motility.
This effect can be reduced by the addition of chemical modulators. BvgAS repressed
the transcription of the flagella master operon (flhDC) in E. coli, which caused nonflagellation of the cell (Han et al, 1999). Down regulation of the flhDC by bvgAS or
more likely BvgA, since BvgA expression alone had the same effect on motility, may
or may not be exclusive. BvgA, instead of acting directly, may activate a repressor
molecule such as one similar to BvgR.

1.2.3. BvgR

The mechanistic control exerted by BvgA may in some cases be direct while in
others be transient. Strong evidence exists to suggest that expression of bvg-
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activated genes, such as fha, cya and ptx, are initiated by the direct binding of
activated BvgA (Boucher et al, 1994; Boucher and Stibitz, 1995; Gross et al, 1992;
Karimova et al, 1996; Roy and Falkow, 1991). The means of 6vg-repressed gene

expression is however not so clear. A model describing the repression of vrgs duri
the expression of vags has been proposed for B. pertussis, which involves a bvgactivated regulator, ie. BvgR. This protein is thought to bind to and repress
transcription of 6vg-repressed genes (Merkel and Stibitz, 1995). An open reading
frame (ORF) situated immediately downstream of the bvg locus encodes a protein of
32 kDa and has been designated bvgR. BvgR is expressed maximally when
environmental conditions are non-modulating (Merkel et al, 1998b).
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Figure 1.3. Model of B v g A S signal transduction. Proposed stages of bvg activation due to the
phosphorelay cascade. Domains have the following abbreviations: S = sensor; L = linker; T =
transmitter; R = receiver; O = output and terminal phosphotransfer domain; H T H = helix turn helix
motif. The phosphoryl group is indicated by the circled P and the cellular membrane is denoted by the
grey bar.

Five &vg-repressed genes of B. pertussis have been identified to date. These are
known as vrg6, vrgl8, vrg24, vrg53 and vrg73. In four of these genes (with the
exception of vrg73) the presence of a conserved sequence element has been revealed.
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A small insertion within the conserved element of vrg6 resulted in constitutive
expression due to the lack of modulation capability (Beattie et al, 1990; Beattie et
al, 1993). Further evidence of a repressor protein came from Southwestern analysis
which demonstrated that the conserved region of vrg6 was bound by a 34 kDa
protein when in non-modulating conditions but not when conditions were modulating
(Beattie et al, 1993). In a respiratory infection model of mice, a strain carrying a
deletion in bvgR was significantly impaired in its capacity to generate disease
(Merkel et al, 1998a). The expression of BvgR in B. bronchiseptica has not as yet
been substantiated.

1.2.4. Bvg-intermediatephase

The BvgAS signal transduction system, as described already, consists of two
phenotypic phases, the bvg+ or "activated" and the bvg', or "repressed". These

phases are characterised by the distinctive set of molecules expressed in each of thes
circumstances. Recently a third phase has been identified that is described as being
an intermediate between the two, ie. bvg1 (Cotter and Miller, 1997). A mutant locked
into this phase displays colony morphology midway between Bvg+ and Bvg".
Colony morphology of Bordetella is Z>vg-dependant. Virulent colonies (bvgactivated) are small, shiny, domed, and haemolytic, whereas avirulent (bvgrepressed) colonies are larger, flat, non-haemolytic with a dull appearance. Bvg'
colonies have an intermediate morphology being, distinct from Bvg phase bacteria
but larger, flatter, less shiny and less haemolytic than Bvg+ phase bacteria. Other
phenotypic traits that exist in this phase are, autoagglutination, an intermediate
ability to survive in nutrient limiting conditions, a unique outer membrane profile
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exhibiting high molecular weight polypeptides absent from B v g and Bvg" phases.
Examples of this phase also display an inability to produce a subset of Bvg+ factors
of which several are antigenic, and they demonstrate a reduced ability to colonise the
rat respiratory tract. This phase has demonstrated again the importance of antigenic
control and the complexity of the system. It is possible that BvgAS mediates the
expression of many phases in response to the environments encountered between and
within host animals.

1.2.5. Bvg-activated genes (vags)

A wide array of well-characterised vag products are produced when the prevailing
culture conditions are non-modulating. The majority of the described vags are
common to both B. bronchiseptica and B. pertussis with pertussis toxin being a
notable exception. Pertussis toxin, as the name implies, is produced by B. pertussis
and is the most important toxin in regard to the clinical disease produced by this
species, ie. "whooping cough" or "pertussis". Both B. bronchiseptica and B.
parapertussis possess the complete toxin operon however this operon remains
transcriptionally silent (Arico and Rappuoli, 1987).

1.2.5.1 Adenylate cyclase-haemolysin
One of the best characterised virulence factors of the Genus Bordetella is adenylate
cyclase-haemolysin (ACH), encoded by the cyaA gene. The cyaA gene of B.
bronchiseptica and B. pertussis encodes a Afunctional toxin exhibiting both
adenylate cyclase and haemolytic activities (Goyard and Ullmann, 1993). Adenylate
cyclase is a secreted, soluble, heat stable, and highly active protein (Confer and
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Eaton, 1982). It is also credited as being a major protective antigen against B.
bronchiseptica infections, with very early anti-ACH antibodies detectable.
Immunisations with purified ACH produced similar protection to that of a whole cell
vaccine. The ACH molecules produced by B. bronchiseptica and B. pertussis are
immunologically different. Sera from mice infected with B. pertussis did not
recognise ACH from B. bronchiseptica, but sera from B. bronchiseptica mice did
react with B. pertussis ACH. This indicates that immunological response in relation
to ACH is directed against different epitopes of these two molecules (Gueirard and
Guiso, 1993).

ACH exhibits homology to the RTX family of pore forming toxins. The toxins C-

terminal portion inserts into target cell membranes and facilitates a translocation o
the enzymatically active N-terminal portion into the cytosol (Rogel and Hanski,
1992). In this way ACH is internalised by phagocytic cells and catalyses the
unregulated formation of cyclic AMP. This is thereby disruptive to normal cellular

function causing the cells to undergo apoptosis, thereby disabling host cell defences
(Confer and Eaton, 1982; Khelef et al, 1993).

Cyclic AMP suppresses a variety of cellular functions including superoxide
production, chemotaxis, bacterial killing, and phagocytosis. Target cells of most
relevance to B. bronchiseptica infection are macrophages, monocytes, neutrophils,
and polymorphonuclear leukocytes. These are all important components of the host
response to infection and may be one explanation as to why humans infected with B.
pertussis are exceptionally vulnerable to secondary infections (Confer and Eaton,
1982).
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The proteins encoded by the cyaA genes of B. bronchiseptica and B. pertussis are
1705 aa and 1706 aa residues respectively and are 98% identical. The N-terminal

400 residues are responsible for adenylate cyclase activity while the 1300 C-terminal
residues correspond to the haemolytic portion (Sebo et al, 1995). Following the

molecules synthesis as an inactive precursor, it is activated by palmitoyation of the
amino group of Lys-983 in the presence of CyaC, an accessory protein (Barry et al,
1991). The cyaC gene is located upstream of cyaA, while downstream of cyaA are
the secretion genes cyaBDE (Glaser et al, 1988). Upstream of the cyaA gene is a
site for binding by phosphorylated BvgA (Karimova et al, 1996).

1.2.5.2. Dermonecrotic toxin
A second toxin produced by all members of the Genus is dermonecrotic toxin
(DNT). DNT exists as a cytoplasmically located, single polypeptide chain with a
molecular weight of 140 kDa (Horiguchi et al, 1990; Nakai et al, 1985). There is
no precise data regarding the role of DNT in the infection process, however the toxic
effects of the molecule are varied and unrefuted (Walker and Weiss, 1994). DNT
will cause characteristic skin lesions when injected intradermally into test animals
such as mice, rabbits and guinea pigs (Livey and Wardlaw, 1984; Walker and Weiss,
1994). As little as 0.4 pg is required for this type of skin reaction (Zhang and
Sekura, 1991). In toxicity trials described by Horiguchi et al, the LD5o of BALB/c
mice following an intraperitoneal administration was 6 ng and with intravenous
administration was just 2.3 ng (Horiguchi et al, 1992).
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D N T is thought to be the cause of the chronic necrosis of pig snouts k n o w n as
turbinate atrophy, a major consequence of the disease swine atrophic rhinitis
(Hanada et al, 1979; Kume et al, 1986). Upon intravenous injection of mice, DNT
was found to cause atrophy of the spleen, accompanied by significant spleen weight
reduction, and suppress in vivo antibody response against both T-cell dependant and
T-cell independent antigens despite the thymus remaining unaffected. A significant
suppression of the antibody response was even seen against E. coli
lipopolysaccharide, a highly immunogenic molecule (Horiguchi et al, 1992). In
addition to necrosis of tissue, DNT is thought to inhibit differentiation of various
types, alter cell morphology, stimulate proliferation of cytoplasmic membrane
organelles, and stimulate DNA and protein synthesis (Horiguchi et al, 1991;
Horiguchi et al, 1993; Senda et al, 1997). These alterations are believed to be due
to an interaction between DNT and the GTP binding protein, Rho. Rho protein
triggers and regulates a variety of cellular responses (Senda et al, 1997).

1.2.5.3. Filamentous haemaglutinin
B. bronchiseptica expresses several adhesion molecules, of which one of major
importance is filamentous haemaglutinin (FHA). This molecule is a 200 kDa surface
associated protein with, as the name implies, a filamentous structure. Adherence to
the ciliated epithelial cells of the respiratory tract is a crucial step in B.
bronchiseptica pathogenesis (Sakurai et al, 1993; Tuomanen et al, 1983). Wild
type B. bronchiseptica grown under Bvg" phase conditions and mutant strains lacking
FHA altogether are incapable of adhering to a rat lung epithelial (L2) cell line. Of

further interest is that a mutant strain constructed to ectopically produce FHA under
Bvg" phase conditions had nearly identical attachment capabilities as the bvg-
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activated wild type for this cell line. These results illustrate that not only is F H A
required, but is sufficient for adherence to L2 cells (Cotter et al, 1998). Further to
this work, in vivo studies with the above mutants demonstrated that although FHA
was not sufficient for B. bronchiseptica to colonise the rat respiratory tract, it was
required (Cotter et al, 1998).

1.2.5.4. Fimbriae
Another important adhesin produced by B. bronchiseptica is fimbriae. Two subunit
genes have been identified, cloned and designated fim2 and fim3 due to the
homology shared with the equivalent genes from B. pertussis. The nucleotide
sequence identity between the B. pertussis subunit genes and those of B.
bronchiseptica is 74% for fim2 and 94% for fim3. The putative -10 and activator
binding regions between the two species are identical (Savelkoul et al, 1996). Not
only are fimbriae known to play a role in the adherence of the bacteria during

colonisation, it is thought that host specificities may be explained in part as a resul
of the polymorphism exhibited by this molecule (Boschwitz et al, 1997; Mooi et al,
1987). A monoclonal antibody specific for an epitope of Fim2 was used to

demonstrate that fimbrial variation is associated with the host species (Burns Jr et al
1993). Strains isolated from dogs showed a greater variation in fimbrial profiles than
strains from pigs. This may indicate that the host specificity of individual B.
bronchiseptica strains is achieved to some extent by the fimbrial structure.

An operon for fimbrial accessory genes is located downstream of the filamentous
haemaglutinin structural gene, fhaB. This operon contains genes encoding the
proteins FimB, FimC, and the minor fimbrial subunit FimD. Fim2 and Fim3 are
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The site

responsible for fimbrial phase variation is said to be cytosine-rich regions upstream
offim2 and fim3. Small deletions or additions in these regions are thought to alter
the distance between the -10 box and activator, thereby somehow altering the
expression of the gene products (Willems et al, 1990).

1.2.5.5. Pertactin

The third and final specialised adhesin of B. bronchiseptica is pertactin. Pertactin is
a 68 kDa outer membrane protein which has been shown to mediate adherence to
several eukaryotic cells lines (Everest et al, 1996). Monoclonal antibodies directed

against pertactin are able to inhibit attachment and internalisation of B. pertussis in
HeLa cells (Leninger et al, 1992). It has also been demonstrated that antibodies
reactive against the protein are detected at high titre in protected piglets and are
therefore able to provide protection against B. bronchiseptica-mediated atrophic
rhinitis (Li et al, 1992; Novotny et al, 1985). A mutant strain deficient in pertactin
was unable to confer protection to piglets in vaccination trials (Novotny et al, 1985).

Pertactin is encoded for by the gene prn. This gene produces a 94 kDa precursor
molecule that is processed to form the 68 kDa protein that exists on the cell surface.
Comparison of the B. bronchiseptica precursor with those from B. pertussis and B.
parapertussis show that greater than 90% homology exists at the amino acid level (Li
etal, 1992).
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1.2.5.6. Serum Resistance
The brk locus of B. pertussis contains two genes, brkA and brkB, and is credited as
being responsible for mediating both resistance to killing by complement and
adherence (Fernandez and Weiss, 1994). However, it has now been demonstrated
that the product of the brk locus, BrkA does not confer serum resistance to B.
bronchiseptica (Rambow et al, 1998). A B. bronchiseptica strain deficient in the
expression of BrkA was susceptible to killing to, and only to, commercially available
guinea pig sera. Following the introduction of intact brkA from B. pertussis,
resistance was not restored to the strain. Furthermore, mutation of brkA in other

strains of B. bronchiseptica did not effect significantly the resistance to sera. It ca
be concluded that BrkA alone does not mediate serum resistance in B.
bronchiseptica. The superior capability of B. bronchiseptica to resist the
complement attack may be due to other phenotypes, such as lipopolysaccharide
(LPS).

1.2.5.7. Type III secretion
The final frvg-activated system to be considered in this review is the type III
secretion system of B. bronchiseptica. A genetic locus (bscN) has been identified
with significant sequence homology to type III secretion systems of other pathogenic
Gram-negative bacteria such as yscN of Yersinia (Woestyn et al, 1994). Various
other bacterial species utilise this type of system to secrete virulence proteins.

Secretion of Type III proteins is not dependant on sec genes but is often initiated by
contact between host cells and bacteria (Lee, 1997). The Type III system is not
responsible for the secretion of any of the known B. bronchiseptica virulence factors
however, deletion of bscN results in numerous phenotypic changes, as seen by the
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absence of multiple, unidentified secreted proteins (Yuk et al, 1998). Such changes

include a reduced ability for long term survival in the rat trachea, cytotoxicity towa
the rat L2 cell line also decreased and an inability to cause tyrosine
dephosphorylation of specific proteins of L2 cells in vitro was observed (Yuk et al,
1998). In Yersinia pseudotuberculosis, YopH, a type III secreted protein, disrupts
phosphotyrosine signalling thereby inhibiting phagocytic activity of macrophages
(Andersson et al, 1996).

1.2.6. Bvg-repressedgenes (vrgs)

Dephosphorylation of BvgA by the deactivation of the sensory cascade results in the
expression of frvg-repressed genes (vrgs). The vrgs have not been as extensively
characterised as the vags. This has meant that the function of the majority of such
genes is still unknown. Genes involved with the production of siderophore and
motility by way of flagella biosynthesis, are the best known of the B. bronchiseptica
vrgs. 27 vrgs of B. pertussis have been identified, however their specific functions
are yet to be determined (Knapp and Mekalanos, 1988; Stenson and Peppier, 1995).
Although it is generally accepted that the purpose of vrgs in relation to early
colonisation-infection is minimal, their importance to in vivo persistence cannot be
overlooked at this time.

1.2.6.1. Siderophore
Successful colonisation of a mammalian host requires the acquisition of iron as it is
an essential co-factor for many biological oxidation-reduction reactions (Weinberg,
1978). Virtually all microorganisms require Fe as an essential nutrient for growth,
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however free Fe concentrations are too low in the mammalian body to support
microbial growth. Extracellular Fe is sequestered in Fe-binding complexes with
proteins such as lactoferrin and transferrin. These complexed proteins maintain Fe
concentrations below the minimum threshold for bacterial growth. This mechanism
is known as nutritional immunity (Weinberg, 1990).

Two strategies exist by which pathogenic bacteria scavenge iron. One common
method involves the secretion of small, non-proteinaceous, Fe-chelating molecules
capable of separating the Fe from lactoferrin and transferrin (Agiato and Dyer, 1992;
Armstrong and Clements, 1993). The siderophore, when associated with Fe, can be
transported across the bacterial membrane following binding with specific receptors.
A second approach is the direct binding of the Fe-protein complex to the cell surface
thereby allowing for direct removal. Both of these strategies are utilised by B.
bronchiseptica and B. pertussis (Menozzi et al, 1991). The siderophore utilised by
B. bronchiseptica is the macrocyclic dihroxamate alcaligin and is identical to the
alcaligin produced by Alcaligenes denitrificans (Moore et al, 1995). The expression
of this siderophore has been shown to be repressed by the bvg locus, in addition to
the ferric iron uptake regulation (Fur) protein, which responds to free iron
concentration (Giardina et al, 1995a). Interestingly, bvg involvement seems to be
influenced by the host species. 28 of 30 (94%) pig isolates were 6vg-independent,
whereas in 57 isolates from 73 other mammals tested (78%>) alcaligin was bvgrepressed. Implications of this data may reinforce the supposition of Akerley et al.
(1995) that suppression of various phase determinants due to bvg repression is
important so as they don't interfere with colonisation. This would suggest that

Introduction

28

alcaligin production by B. bronchiseptica is essential for colonisation of pigs but m a y
not be crucial for other hosts (Giardina et al, 1995b).

1.2.6.2. Acid phosphatase
The enzyme acid phosphatase has been recognised as a virulence factor in various
bacterial species, such as Legionella micdadei (Dowling et al, 1992), Coxiella
burnetii (Baca et al, 1993) and Leishmania donnvani (Glew et al, 1988). These
enzymes play an intracellular role by providing protection from superoxide anions,
generated by host cells. Of the Bordetellae, B. bronchiseptica is the only species
known to express the enzyme (Chhatwal et al, 1997). It was shown in this study that
the acid phosphatase expression of this species seems to be activated by a
temperature dependant regulator, that is itself partially repressed by the bvg locus.
The wild type strain BB7865 demonstrated a marked increase in enzyme expression
in the presence of chemical modulators at 30°C. This activation would seem typical

of other 6vg-repressed phenotypes however, it is only under these conditions that this
strain shows significant expression. Significantly lower activities were observed at
30°C in a non-modulating background suggesting the requirement of bvg repression
for acid phosphatase expression. Comparisons of survival rates between wild type
strains and acid phosphatase mutants suggest that this enzyme is involved in survival
within dendritic cells.

1.2.6.3. Motility

The motility of B. bronchiseptica is achieved by frvg-repressed, peritrichous flagella
The regulation of the flagella filament biosynthesis involves a complex
transcriptional cascade (Akerley et al, 1992). The initiation point for this
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biosynthesis cascade in B. bronchiseptica is the frl (flagella regulatory locus) gene
consisting offrlA and frlB (Akerley and Miller, 1993). Flagella production directly
correlates with frl mRNA synthesis. Further to this point, primer extension
experiments revealed that the frl promoter is directly regulated by BvgAS at the
transcriptional level (Akerley et al, 1995). The flhDC operon of E. coli is
considered the major regulon of motility due to it containing the early genes of the
flagella biosynthesis hierarchy in this species. The frlAB genes of B. bronchiseptica

will efficiently complement flhDC mutants in E. coli indicating that frlAB is required
for motility and the production of flagella in B. bronchiseptica. Cloning of the FHA
promoter in front of frl results in expression of flagella biosynthesis in a bvgactivated phase, along side the vags (Akerley et al, 1995).

1.2.7. Mechanisms of intracellular survival

The capacity to survive within eukaryotic cells is obviously beneficial to a
bacterium's ability to maintain infection. B. bronchiseptica has developed
specialised abilities, possibly through regulation by the BvgAS system, for evasion
of host antibacterial activity. An array of mechanisms exists for the inhibition of
such processes as phagosome-lysosome fusion (Steed et al, 1991), resistance to
lysosomal enzymes, oxidative stress, antimicrobial peptides, and serum attack
(Banemann et al, 1998; Fernandez and Weiss, 1994; Jungnitz et al, 1998; Rambow
et al, 1998). B. bronchiseptica has also demonstrated the ability to escape from the
phagocytic vacuole and adapt to environments of low pH (Schipper et al, 1994).
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Not all factors involved with virulence and/or survival are strictly or simply
controlled by the bvg locus. This point is exemplified by the phenotypic changes
observed with the 5vg-intermediate phase. Also, other factors are indeed influenced
by Bvg but not uniquely controlled by it. One such phenotype is that of urease.

Urease is a multi-subunit, nickel based enzyme that is responsible for catalysing the
conversion of urea to ammonia and C02 (Mobley et al, 1995). In B. bronchiseptica

there are 8 genes directly associated with urease biosynthesis that are organised int
an operon of approximately 8 kb (McMillan et al, 1998). The regulation of urease
appears to be partially controlled by bvg. In the wild type strain, BB7865, urease is
only expressed at 37°C in the presence of sulfate ions, a characteristic of bvgrepressed phenotypes. This finding is supported by the constitutive urease
expression by a 6vg-repressed phase locked mutant of BB7865 (BB7866). However,
urease is not expressed at the lower growth temperature (30°C), indicating a bvgactivated phenotype. The mechanism for the regulation of urease in B.
bronchiseptica is a complex situation requiring factors other than bvg alone. The
function of urease in this species is thought to possibly be one of intracellular
survival, combining with several other proteins in response to phagolysosomal attack
(McMillan et al, 1998).

Highly reactive oxygen anion radicals are an effective intracellular defence
mechanism employed by the host. Intracellular bacteria can utilise various enzymes,
such as super oxide dismutase (SOD), and catalase for the conversion of these
radicals to more stable forms, ie. 02" to H202 and 02 (DeShazer et al, 1994; GraeffWohlleben et al, 1997). These enzymes are thought to be active within the
phagolysosomal compartment. Further to this point, mutants deficient in acid
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phosphatase activity are reduced in their invasive ability (Chhatwal et al, 1997).
The respiratory burst, an intracellular process responsible for the generation of
destructive superoxide radicals, is inhibited by acid phosphatase (Baca et al, 1993).
Acid phosphatase is under the regulation of a newly identified locus in B.
bronchiseptica known as ris (Jungnitz et al, 1998). A second two component
sensory system is encoded by ris, and is known to be upregulated following
internalisation into HeLa cells. Mutants deficient in ris expression are more
susceptible to oxidative stress and are unable to persist in murine lungs.

1.2.8. Lipopolysaccharide

Another molecule that is influenced by the Bvg, but not obviously a vag or a vrg, is
lipopolysaccharide (LPS). LPS is a highly toxic and immunogenic molecule that
constitutes a major component of the cell membranes of Gram-negative bacteria and
is a major distinguishing factor between Gram-negative and Gram-positive bacteria
(Preston et al, 1996). Regulation of the LPS genes is as yet not well defined in
Bordetella. There are some indications that the bvg locus is involved in regulating
LPS biosynthesis of some strains of B. bronchiseptica but is not utilised for B.
pertussis LPS regulation (van den Akker, 1998). Isogenic bvg' phase mutants of B.
bronchiseptica display an LPS profile analogous to that of a modulated wild type
strain indicating a role for BvgAS in the LPS biosynthesis of at least some strains of
B. bronchiseptica (van den Akker, 1998). Growth temperature is an important
modulator of LPS expression in both B. bronchiseptica and B. pertussis but unlike B.

bronchiseptica, this form of regulation in B. pertussis is independent of the bvg locu
(van den Akker, 1998). At a growth temperature of 37°C the LPS that exists is
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almost entirely composed of band A L P S , whereas culture at 25°C results in
increased expression of band B LPS. The LPS profile of a bvgS mutant (Bvg"
phenotype) was identical to that of the parental strain therefore the bvg locus is not
responsible for the LPS temperature modulation observed in B. pertussis.

1.2.9. Aims of the Study

The major objectives of this thesis are to investigate particular systems or genes,
which were identified as possibly important for the pathogenesis of B.

bronchiseptica, ie. motility, and later, LPS biosynthesis. The motility phenotype will
be examined by initially characterising several motility mutants of B. bronchiseptica
BB7866 and B. bronchiseptica BB7865, and by further utilising in vitro eukaryotic
cell invasion and survival assays. The importance of LPS to the pathogenesis of B.
bronchiseptica will be determined by investigating a gene involved early in the
biosynthesis of the LPS molecule, known as phosphoglucomutase (PGM).
Following a characterisation of the genetic organisation of pgm, a mutant of the wild
type strain BB7865, defective in the expression of PGM, will be characterised by a
wide array of in vitro and in vivo assays. These assays will include biochemical
analysis of PGM, structural analysis of the resultant LPS molecule, and influence of
LPS to survival in in vitro cell culture assays and ultimately within a murine
respiratory model. Further detail of the studies objectives precedes each chapter.
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EXPERIMENTAL PROCEDURES

2.1. Bacterial strains, plasmids and growth conditions

Recipes for all media and buffers are listed in appendix I. All bacterial strains an
plasmids which appear in this study, are compiled in Table 2.1 and Table 2.2.
Bordetella strains were grown on Bordet Gengou (BG) agar (Bordet and Gengou,
1906) (Difco) containing defibrinated horse blood (10%, v/v) and Stainer and
Scholte medium (SS-X) (Stainer and Scholte, 1971) or a modulating version of SS-X
containing 40 mM MgS04 replacing NaCl (SS-C). Liquid cultures were also grown
in SS-X or SS-C. E. coli strains were grown on Z agar (Walker et al, 1988) or in
Luria Bertani (LB) broth (Sambrook et al, 1989). When required, antibiotics were
used at the following concentrations: cephalexin 50 ug.ml" ; kanamycin 50 ug.mi"1;
ampicillin 100 ug.ml"1; rifampicin 100 ug.mi"1; naladixic acid 50 ug.ml"1;
trimethoprin 50 ug.ml"1. Isopropyl-[3-D-galactopyranoside (IPTG, 0.04 mM) and 5bromo-4-chloro-3-indolyl-p-D-galactopyranoside (X-gal, 0.004%, w/v) were used
where appropriate. All incubations were performed at 37°C unless otherwise stated.

Liquid cultures were agitated during incubation in an orbital-shaking incubator when
required.
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Table 2.1. Bacterial strains used in this study

Strain

Genotypea or
Phenotype

Source/Referen ce

cPr

(Monack etal, 1989)

Bordetella bronchiseptica

BB7865
r

r

BB7865RifNal

Cp , Rif, Nal

VMM1

r

(Smith and Walker, 1996)

bvg+, mini-Tn5 lacZl

This study

bvg

(Monack et al, 1989)

BB7866
AMM1

bvg', mini-Tn5 lacZl

This study

AMM2

bvg', mini-Tn5 lacZl

This study

AMM3

bvg', mini-Tn5 lacZl

This study

AMM4/BB7866>gm

bvg',pgm, mini-Tn5 lacZl
+

BB7865/?gm

bvg ,pgm, mini-Tn5 lacZl,

This study
This study

Tpr, Nalr, Rif
bvg+, pgrn, mini-Tn5 lacZl,

BB7865pgm
+

(pBBRlMCS-4/pgw )
BB7866ra
BB7865ra

r

r

Tp , Nal , Rif, A p

This study

r

bvg', mini-Tn5 lacZl
+

(Jungnitz^a/., 1998)
r

bvg , mini-Tn5 lacZl, Tp ,

(Jungnitze^a/., 1998)

r

Nal , Rif
B. pertussis Tohama I

(Sato and Arai, 1972)

B. parapertussis A T C C 1 5 3 1 1

M . Hofle

B. avium A T C C 3 5 0 8 6

M . Hofle

E. coli
(Yanisch-Perron et al, 1985)

JM109
S M 1 0 X.pir

A,pir

(Miller and Mekalanos, 1988)

S17Xpir

Xpir

(Miller and Mekalanos, 1988)

294 Rif

Rif

(Talmadge and Gilbert, 1980)
(Bowen and Pemberton, 1985)

Q358

Invitrogen

One Shot Cells

Abbreviations: cephalexin

(Cp); rifampicin

(Rif); nalidixic

acid

(Nal);

trimethoprim (Tp); Bordetella virulence gene locus (Bvg); (3-galactosidase gene
(lacZ); phosphoglucomutase (pgm).
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Table 2.2. Bacterial plasmids used in this study.

Plasmid

Genotype*
or Phenotype
Kmr, lacZ

pUT::mini-Tn5 lacZl

Source/Reference
(de Lorenzo et al, 1990)

pUC18

Ap , lacZa

(Yanisch-Perronera/., 1985)

pHC79

Apr, Tcr

(Prieferefa/., 1984)

Cmr, lacZa

(Takeshita et al, 1987)

r

pHSG398
pHSG398WorI'white

Cm'

pR715::TnSii

r

Yan Huaru
r

Tp , Km

(Bowen and Pemberton, 1985)

r

pBBRlMCS-4

Ap

pBBRlMCS-4//pgm+

(Kovach ef a/., 1995)

Apr, pgm

This study

mini-Tn5 lacZl, Kmr, Apr

pNW6
pNW17

lacZ, Cm
r

pNW19

Ap

pNW23

pgm+, Apr
pgm , Cm
r

pCR2.1

Abbreviations:
chloramphenicol

Ap , Km

kanamycin

1

r

( K m ) ; ampicillin

( C m ) ; trimethropim

This study
This study
This study

+

pNW24

3

r

This study
This study
Invitrogen

(Ap); tetracycline (Tc);

(Tp); (3-galactosidase gene (lacZ);

phosphoglucomutase (pgm).

2.2. Protein Manipulations
2.2.1. Flagella purification

During the flagella isolation procedure all centrifugation steps were conducted at
4°C. A 10 m l seed culture of B B 7 8 6 6 in modified Cohen Wheeler medium was
incubated at 37°C with shaking for 24 h. A 5 m l sample of this seed culture was
inoculated into two individual two litre conical flasks containing 500 m l of Cohen
Wheeler medium. These cultures were then incubated statically for 48 h at 37°C.
Following incubation, the cultures were subjected to a series of centrifugation steps.
Thefirstinvolved a low speed spin of 2200g for 20 min to separate the cells from the
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medium. The cells were then resuspended in P B S p H 7.4 and combined to a final
volume of 100 ml, then centrifuged at 2200g for 20 min to remove all remaining
medium. The supernatant was discarded and the cells were resuspended in
approximately 80 ml of PBS pH 7.4. The cell suspension was then homogenised on
ice with a Kinematica Polytron® on speed setting 2, in two bursts of 2.5 min with a
pause of 2.5 min between bursts. The homogenate was centrifuged twice to separate
the cell debris. The first centrifugation was carried out at 12000g for 45 min,
followed by a second spin of 14600g for 30 min. The supernatant was retained and

the pellet discarded. In order to precipitate the flagella, 1 M MgCl2 was added to t

supernatant at a ratio of 1:9 respectively and incubation carried out overnight at 4
The supernatant containing the flagella precipitant was centrifuged at high speed

(43700g for 60 min) to recover the flagella pellet. The product was then resuspended
in PBS pH 7.4 and analysed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS PAGE).

2.2.2. Polyclonal anti-serum production

2.2.2.1. Immunisation
A pre-immunisation bleed was conducted via the marginal ear vein of a 3 month old

female New Zealand white rabbit to obtain sera at time 0 to act as a negative contro
The protein concentration of a purified flagella sample was determined using the
Pierce Micro BCA Protein Assay Reagent Kit. Purified flagella at a concentration of
50 ug.ml"1 was combined with a 1:1 volume of Freunds incomplete adjuvant to a
total volume of 2 ml. The selected 3 month old New Zealand white rabbit was
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immunised via 4 subcutaneous injections of 500 ul each to the fore and hind
quarters.

At 7 days post immunisation, 1 ml of serum was collected from the marginal ear vein

in order to monitor the antibody response against flagella. Also at this time a secon
immunisation, which followed the procedure outlined above, was administered. The
rabbit was exsanguinated at 14 days after the initial immunisation via a heart
puncture. Prior to this the rabbit was anaesthetised with 1.5 ml of Nembutal.
Approximately 100 ml of blood was extracted from the rabbit from which 50 ml of
serum was collected. Prior to collecting the serum, the blood was left at room
temperature to coagulate for 1 hour. Subsequently the clot was dislodged and the
sample centrifuged at lOOOg for 10 min to separate the serum from the cellular
fraction. The serum was then aliquoted and stored at -20°C.

2.2.2.2. Cross absorption of anti-serum
Anti-serum was cross absorbed with whole cell VMM1, a virulent mutant of BB7865
which had been shown to be deficient of flagella. Two to three loopfuls of bacteria
were resuspended in 5 ml of the polyclonal anti-serum and incubated at 37°C for 30
min. Following this incubation period the sample was centrifuged at 14000g to
pellet cells. The serum was transferred to a fresh tube and the procedure repeated
another four times.

Samples of boiled VMM1 were also used to cross absorb any antibodies specific for
B. bronchiseptica cytoplasmic proteins. Such antibodies were present in the preimmune serum. Cells that were grown on BG agar were taken and suspended in 600

Experimental Procedures

38

ul of physiological saline (0.7% NaCl). The sample was then boiled for 15 min,

which yielded a concentrated cell lysate. 200 ul of this sample was added to the 5 m
sample which had been previously cross absorbed with whole cells. The sample was
incubated for 30 min at 37°C after which it was centrifuged at 14000g for 10 min to
pellet the cells. The sera was transferred to a fresh tube and this procedure was
repeated twice more.

2.2.3. Sodium dodecyl sulfate polyacrylamide gel electrophoresis of proteins

Protein samples were prepared for SDS PAGE by boiling with sample buffer (1:1)
for 10 min. All protein samples were run on 10% polyacrylamide gels at voltages
ranging from 60 to 100V. Bio-Rad low range molecular weight standards (10 ul)
were run on gels intended for staining with 2%> Coomassie blue, whereas Bio Rad

prestained low range molecular weight standards (6 ul) were run on gels intended fo
western transfer.

2.2.3.1. Transfer to P VDF
SDS PAGE gels were electrophoresed at 60-80 volts and contained prestained
molecular weight standards. The gels were then cut down to a minimum size by
removal of the stacking gel. Equilibration of the gel and PVDF membrane was then
performed by soaking in 200 ml of western transfer buffer (Appendix I) for 30 min.
Prior to this the membrane was "wet" with 70% ethanol. The protein transfer was
accomplished using a Bio-Rad semi-dry transfer cell set at 15 volts for 20 min. The
transfer system was set up in the following manner. Five sheets of Whatman blotting
paper were moistened with western transfer buffer and placed onto the positive
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electrode. The P V D F was positioned on top of thisfirststack, followed by the gel,
and five more sheets of blotting paper. Upon completion of the transfer, the
membrane was blocked with 5% low fat milk for 60 min.

2.2.4. Western hybridisation

Following transfer of proteins to a PVDF membrane and blocking of non-specific

binding sites, the rabbit anti-flagella antibody was added at a dilution of 1:200 in
PBS. The blot was allowed to incubate at room temperature with gentle shaking for
60 min. Three 10 min washes with PBS were conducted after incubation with the

first antibody. Goat anti-rabbit horseradish peroxidase conjugated antibody was then
added as the second antibody at a dilution of 1:1000 and the incubation and washing
steps conducted as above. The blot was developed by the addition of western
development solution, washed and dried.

2.3. DNA Manipulations
2.3.1. The fundamentals

2.3.1.1. Restriction and electrophoresis of DNA
The restriction endonucleases used were all obtained from various commercial
sources. A typical reaction consisted of 10 ul sample of DNA, 6 ul of dH20, 2 ul of
the respective lOx buffer according to the suppliers instructions, and 2 ul of the
particular enzyme. The reaction was commonly incubated at 37°C for 1 h. After
digestion, the sample was heated to 75°C for 15 min to denature the enzyme and 2.5
ul of DNA loading dye was added. Electrophoresis of DNA was performed in
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0.85% agarose/TAE gels in a BioRad mini-sub electrophoresis chamber (BioRad), at
60-80 volts for approximately 2.5 h. For Southern hybridisation, gels were run
overnight at 12 volts. Visualisation of the DNA was achieved by immersion in 0.5
ug.ml"1 ethidium bromide for 30 min followed by illumination with UV light.

2.3.1.2. Ligation
Ligation of DNA was achieved by setting up a 20 ul reaction mix containing
approximately a 3:1 ratio of insert to vector DNA. The reaction was heated to 65°C
for 1 min followed by subsequent incubations at 37°C, room temperature, and on ice
for 10 min each. 1 ul (1 unit) of T4 DNA ligase was then added and the reaction
incubated at 8-12°C overnight.

2.3.1.3. Transformation
E. coli JM109 was made chemically competent to facilitate the uptake of
recombinant plasmids. Cells were cultured in LB broth to an OD of 0.5 at 560 nm.

Following centrifugation to pellet the cells, they were left on ice for 10 min before
being resuspended in 100 ml of chilled 0.1 M MgCl2. The cells were centrifuged and
resuspended in 10 ml of chilled 0.1 M CaCl2 then left overnight at 4°C.

The DNA sample (5-10 ul) for transformation was mixed with 200 ul of competent

cells and left on ice for 60 min. To facilitate the uptake of DNA the reaction mixtu
was "heat shocked" at 37°C for 5 min. Following this incubation the cells were
centrifuged, resuspended in 500 pi of LB broth, incubated at 37°C for 60 min and
plated onto selective medium.
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2.3.1.4. Plasmid DNA extraction
For routine small-scale extraction of plasmid DNA, the FlexiPrep Kit, an alkaline
lysis based system from Pharmacia Biotech was used. Briefly, bacteria were grown

overnight in either 1.5 ml liquid cultures or on nutrient agar plates. A cell pellet w
mixed with 200 pi of the resuspension buffer (Solution 1) containing RNase. The
cells were then lysed by the addition of 200 pi of solution 2 and shortly after
neutralised by the addition of 200 pi of solution 3. Following isopropanol
precipitation of the DNA, a silica matrix solution was added to which the DNA
binds. After washing the DNA bound silica, the DNA was eluted with 50 pi of dH20
or TE buffer and stored at -20°C until needed.

For plasmid extraction of a larger scale, the DNA was obtained via Qiagen midi-prep
columns in accordance with manufacturer's instructions (Qiagen). Briefly, the
fundamental mechanism is essentially the same as that described above with a few
key differences. This procedure allows the starting culture volumes to be greater,
therefore significantly increasing the final DNA concentration. Following alkaline
lysis of the host cells they are loaded onto a large volume, DNA binding column.
This column is washed several times prior to eluting the DNA. The procedure was
found to provide high yields of quality plasmid DNA.

2.3.2. Chromosomal DNA extraction

2.3.2.1. Phenol extraction
Chromosomal DNA was extracted as previously described (Priefer et al, 1984). The
strains from which chromosomal DNA was to be extracted were grown on BG plates
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for 48 h. Cells from 1 plate were then suspended in 25 ml of 1.0 M NaCl and shaken
on ice for 60 min. This suspension was centrifuged at 11500g for 10 min at 4°C.
The resulting pellet was resuspended in 25 ml of chilled TES buffer and the
centrifugation repeated. At completion of this stage the pellet was resuspended in
ml of chilled modified TE buffer. 1 ml of lysozyme in TE (2 mg.mi"1) solution was
added to give a final concentration of 0.2 mg.ml"1 lysozyme and incubated at 37°C
for 15 min in order to degrade the cell wall. All protein was solubilised by the
addition of a solution consisting of 1.2 ml of 10% SDS and 5 mg.ml"1 protease and
incubated overnight at 37°C with gentle shaking.

The protein was extracted by twice adding 5 ml of TE saturated phenol, mixing
thoroughly and centrifuging at HOOOg for 10 min between each extraction. Each
time the upper aqueous phase was retained. Following the phenol extraction the
upper aqueous phase was washed with diethyl ether and centrifuged at 16000g for 3
min, the upper organic phase was then discarded and the step repeated. A solution of
3 M sodium acetate was added at a volume 1/10 of that of the solution and 2.5
volumes of cold ethanol were added in order to precipitate the DNA. The solution
was then centrifuged at 16000g for 5 min to pellet the DNA. The DNA pellet was
dried and then dissolved in dH20 containing 20 ug.ml"1 RNase. The integrity of the
DNA was then analysed by electrophoresis in an agarose gel.

2.3.2.2. Gel chromatography extraction
Alternatively, the chromosomal DNA of some strains was extracted with a genomic
extraction kit supplied by Qiagen, in accordance with manufacturer instructions.
Briefly, following culture of cells in liquid medium they were harvested via
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centrifugation and resuspended in a neutral buffer. The cells were lysed with a
lysozyme solution containing proteinase K and the lysate loaded onto a gel
chromatography column. The chromosomal DNA was retained by the gel matrix
where it was washed to separate it from other cellular contaminants. The application
of an elution buffer recovers the chromosomal DNA at which stage it is precipitated
from the elution buffer, resuspended in TE buffer and stored at -20°C until needed.

2.3.3. Conjugation

For procedures reliant on conjugation the general method was as follows. Donor (E.
coli) and recipient strains (B. bronchiseptica) were cultured to confluent growth on
solid selective medium. Approximately 25% of the growth from each plate was
combined in 1 ml sterile saline (0.7%). After thorough mixing, 500 pi of mixture
was applied to BG agar and incubated at 37°C for 1-2 days. 50%o of the resultant
growth was suspended in 0.7%> sterile saline and serially diluted. These dilutions
were plated onto selective medium and incubated at 37°C until colonies were
apparent.

2.3.4. Mini-transposon mutagenesis

Conjugation between B. bronchiseptica BB7865 or BB7866 and the donor E. coli
SMlO^pir containing the suicide plasmid, pUTmini-Tn5 lacZl (de Lorenzo et al,
1990) were performed as above. Transconjugants were selected from the resultant
growth by plating onto SS-X medium at 37°C containing cephalexin, kanamycin, Xgal and IPTG. The antibiotic cephalexin selects for B. bronchiseptica and
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kanamycin selects for the mini-transposon (Figure 2.1), which causes the genetic
disruption. X-gal and I P T G allows for blue/white selection of colonies that received
the transposon in frame with trp '-lacZ. Mutants were subsequently screened for a
non-motile phenotype by w a y of a standard motility assay.

Figure 2.1. Diagrammatic representation of the mini-Tn5 lacZl transposon. This transposon was
utilised to generate motility mutants in B. bronchiseptica B B 7 8 6 6 and B. bronchiseptica BB7865.
The transposon contains a 3.1 kb trp'-lacZ gene and a 1.7 kb kanamycin gene. Restriction enzyme
sites of significance are shown (de Lorenzo etal., 1990).

2.3.5. Motility assay

Standard motility assays were performed in SS-C or SS-X medium containing 0.4%
agar. Selected colonies were stabbed into the semi-solid agar and incubated for 48 h
at 37°C. The motility of the organism was determined as spread of the bacteria from
the point of inoculation, compared with that of the parental control.

2.3.6. Cosmidcloning

Chromosomal DNA to be cosmid cloned was first prepared to the desired fragment

length by partial digestion as a result of a serial dilution of the restriction enzy
SauSA. A set of 6, 1.5 ml microfuge tubes were each loaded with chromosomal
DNA, dH20, and Sau3A restriction enzyme buffer. An aliquot of 2 U of Sau3A
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restriction enzyme was added to thefirsttube and a 2 fold serial dilution performed
on the remaining tubes (Figure 2.2). The reactions are then incubated for 30 min at
37°C after which they were heated to 75°C to denature the enzyme. This procedure
yielded DNA with an approximate fragment length required for cloning into pHC79,
ie. 35-40 kb.

2

U Sau3A

30 ul

""V^

60 ul
DNA +
buffer

30 ul

30 ul

vvvvvv

Discard 30 |il

30^1
DNA +
buffer

i i i ; ; &i

Figure 2.2. Diagrammatic representation of a SauiK serial dilution and subsequent partial digestion
of chromosomal DNA, as seen by electrophoresis.

Cosmid D N A (pHC79) was prepared by digestion with Bamill, as this enzyme
produced sticky ends homologous to those produced by Sau3A. The two DNA
samples were mixed together and ligated. These recombinant cosmids were then
packaged into X phage "Max Plax" kits (Astral) by the addition of 2-5 pi of cosmid
DNA followed by an incubation of 60 min on ice. Transduction of treated E. coli
294 Rif cells was accomplished by incubating the mix at 37°C for 60 min. Before
plating onto selective agar the cell suspension was allowed to express at 37°C for
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2.3.7. Southern hybridisation analysis

2.3.7.1. Alkaline transfer
A wick consisting of three sheets of Whatman blotting paper was prepared and
overlaid on a glass plate which was positioned over a glass tray (Figure 2.3). The
wick was moistened with 0.4 M NaOH with care taken to avoid bubbles. A 0.4 M
solution of NaOH was then added to the tray, immersing the wick ends. The bottom

right corner of the gel was cut off, wells were removed and the gel inverted. DNA in

the gel was depurinated by soaking in 500 ml of 0.25 M HC1 for 5 min, then rinsed in
dH20 for 1 min. Just prior to placing the gel onto the wick, the wick was saturated
with NaOH. The edges of the gel were covered with plastic wrap, so as to avoid

contact between the wick and the paper stack which would effectively 'short-circuit'
the transfer.

The membrane was pre-wet in dH20 and lowered onto the inverted gel ensuring
there were no bubbles. Four pieces of pre-wet Whatman paper of identical size to
the membrane were then overlaid onto the gel. A stack of absorbent paper
approximately 10 cm high was placed onto the filter paper and a glass plate with a
500 g weight were then placed on top. Transfer was conducted for 16 to 24 h.
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ALKALINE TRANSFER

I

glass plate

500g

blotting paper
membrane

—-———-

—

~ | gel
glass plate

v I 1
wick

glass dish

Figure 2.3. Alkaline transfer system employed for Southern hybridisation.

Following transfer, the membrane was rinsed in 2X SSC for 10 min, placed between

two sheets of filter paper and baked at 120°C for 30 min. The membrane was sealed
into a plastic bag and stored at 4°C until hybridisation.

2.3.7.2. DNA probe preparation
DNA probes were prepared using a nick translation kit (Gibco-BRL). The reaction
was prepared by mixing probe DNA (25-30 r|g), dH20 (to bring final reaction

volume to 50 pi), Solution A (5 pi) and radioactively labelled a-32p dATP (5 pi).

After mixing, 5 pi of solution C (enzyme) was added and the reaction was incubated
for 60-90 min at 15°C. After incubation, 5 pi of solution D was added to stop the
reaction. The probe was then purified through a 1 ml Sephadex spin column.

The Sephadex column was prepared in a 1 ml syringe. Sterile glass wool was used to
plug the end. DNA grade Sephadex G50-medium, pre-equilibrated in STE/SDS at
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65°C was added. The column was centrifuged in a bench centrifuge for 5 min at full
speed, to pack the column. This stage was repeated until a continuous column of 0.9
ml volume was achieved. The column function was tested by adding 100 pi STE and
centrifuging for 5 min until 100 pi eluant was obtained consistently.

The DNA probe was then brought to a volume of 100 pi with STE and added to the
column. The column was then centrifuged as before and the purified probe collected.
To remove any remaining probe the column was washed with 100 pi of STE. This
wash gave a final volume of 200 pi. The level of incorporation of the 32p Was then
measured by taking a 2 pi sample of probe DNA in 5 ml of scintillant and
determined with a scintillation counter.

Probes were alternatively DIG labelled (Roche) according to manufacturer

instructions. This procedure differed in that the probe was labelled with a protein
(DIG) and following hybridisation detected with an anti-DIG antibody conjugated to
a chemiluminescent molecule.

2.3.7.3. Hybridisation and autoradiography
Membranes and interleaving nylon meshes were pre-wet with 0.5 M NaHP04 and
inserted into a hybaid® bottle. The NaHP04 solution was then poured off and 20 ml
of hybridisation buffer added. The membranes were then incubated at 65°C for 10
min. This hybridisation buffer was then replaced with fresh buffer and the
membrane was incubated for 60 min at the same temperature.
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The probe was denatured by heating to 100°C for 5 min then incubated on ice. After
cooling, 800 pi of hybridisation buffer at 65°C was added to bring the total probe
volume to 1 ml. The probe was then added to the bottle containing the membrane,
and incubation carried out for 16-18 h with rotation at 65°C. Following incubation,
four washes of the membrane were performed. Two washes at 65°C in Southern
washing solution 1 were performed for 45 min each, followed by two washes with
Southern washing solution 2, also at 65°C.

Upon completion of the washing, the membranes were gently blotted onto filter
paper and sealed in individual plastic bags. X-ray film was exposed to the membrane
for a time dependant on the radioactivity of the membrane. After exposure, the film
was developed for 2 min in X-ray rapid developer (Kodak), rinsed in water, and
fixed for 2 min in rapid fixer (Kodak). Film was rinsed in running water for 15 min
before drying. Hybridisation and chemiluminescent detection of DIG labelled probes
was performed in strict accordance with manufacturer instructions.

2.3.8. Colony hybridisation

Colonies from the cloning experiments were screened by colony hybridisation in
order to identify "positive" clones. Nitrocellulose disks were overlaid directly onto
nutrient agar plates, onto which selected colonies were directly "picked and
patched". The plates were incubated at 37°C for 24 h, at which time the
nitrocellulose was removed and subjected to several treatments. Placing the
membrane onto blotting paper saturated in a 0.4 M NaOH solution lysed the
colonies. Two final treatments of 0.25 M HC1, and dH20, were conducted in the

Experimental Procedures

50

same manner for 5 min each. D N A from the colonies were cross linked to the
membrane with a UV Stratalinker 1800 (Stratagene) and probed as described in
section 2.3.7.3 above.

2.3.9. Polymerase chain reaction

2.3.9.1. PCR procedure

The polymerase chain reaction (PCR) was utilised to amplify a specific chromosoma
DNA segment from B. bronchiseptica. The reaction mix used for the amplification
is described in Table 2.2.

Table 2.3. Composition of the PCR reaction mix.

Component

Volume/Amount

Template D N A

2 Ml/8 ng

Primer mix

4 ul/10 uMeach

dNTP mix

4 ul/2.5 m M each

lOxTaq buffer

10 ul

Taq polymerase

0.5 |il/2.5U

MgCl 2

1 ul/lOOmM

dH 2 0

78.5 ul

The primers were synthesised by Auspep (Australia) or Bresatec (Australia) and the
reaction was performed using a GeneAmp 9600 System (Perkin Elmer, USA). The
cycling parameters used are shown in Table 2.3.
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Table 2.4. P C R cycling parameters used in this study.

Temperature

Duration

Denaturation

94°C

5 min

Annealing

55°C

3.5 min

Extension

72°C

1.5 min

Function

1

Cycles

Denaturation

94°C

40 sec

Annealing

55°C

30 sec

Extension

72°C

1.5 min

39

Cycles

Denaturation

94°C

1 min

Annealing

55°C

1 min

Extension

72°C

5 min

Cycles

1

2.3.9.2. Cloning ofPCR products
The extra deoxyadenosine base generated by Taq polymerase at the 3' end of the
PCR product can be utilised in the cloning of the fragment. The TA Cloning Kit
(Invitrogen, USA) exploits these single base overhangs for direct cloning into the
vector pCR2.1. This vector is supplied linearised and possesses single
deoxythymidine overhangs on the 3' ends, which enables simple ligation with the
PCR product. Standard ligation procedures were utilised to generate a recombinant
plasmid incorporating the two, which was subsequently transformed into 'One Shot
Cells' provided.
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sequence determination and analysis

Automated DNA sequencing, utilising the Sanger method (Sanger et al, 1977), was
performed on plasmid DNA using the Perkin Elmer ABI Prism 377 DNA sequencer.
Three different reaction mixes were used, ie. Perkin Elmer Dye Terminator, Perkin
Elmer dRhodamine Terminator and BigDye terminator cycle sequencing ready
reaction mix. DNA to be sequenced was prepared by dialysing against milli-Q dH20

for 30 min (Millipore, USA) before adjusting to the correct concentration. Universa
Ml3 forward and reverse primers were purchased (Bresatec, Australia), as were
subsequent internal primers. A 20 pi reaction mix contained approximately 0.4 pg
double stranded template DNA, 3.2 pmol of primer, 8 pi of terminator reaction mix,
1 pi DMSO, and dH20 to 20 pi. The amplification was performed in a Perkin Elmer
GeneAmp 9600 thermocycler (Perkin Elmer), with the program conditions as shown
in Table 2.5.

Table 2.5. Amplification parameters for D N A sequencing.

Function

Temperature

Duration

Denaturation

95°C

30 sec

Annealing

50°C

15 sec

Extension

60°C

4 min

Cycles

25

Purification of the extension products generated at the amplification stage was
achieved by combining with 50 pi of 100% ethanol and 2 pi of 3 M sodium acetate

(pH 4.3). The mixture was incubated on ice for 10 min prior to centrifugation at
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16000g for 30 min. The resultant supernatant was discarded and the pellet washed
with 200 pi of 70% ethanol and air dried.

Electrophoresis of the DNA samples occurred through a 48 cm, 0.2 mm thick, 4%
acrylamide (19:1) gel. The gel was prepared and cast in strict accordance with the
ABI Prism 377 user manual. Prior to loading, sample pellets were dissolved in 4 pi
of DNA sequencing loading dye and heated to 90°C for 2 min to denature, and stored
on ice until required.

Contiguous sequences were constructed using AutoAssembler software (Perkin
Elmer) and potential ORF identified by alignment to the GenBank database located
at ANGIS (Australian National Genomic Information Service;
http://www.angis.org.au) by utilising the Blastp algorithm. The resultant ORFs were
directly aligned with those of other species with high homology using the ClustalW
program (Thompson et al, 1994).

2.3.11. Phosphoglucomutase andphosphomannomutase activity assays

Crude lysates were prepared from the strains to be tested for mutase activity using a
modified method from Sandlin and Stein (1994). Cultures of the strains were grown
in either SS-X at 37°C or SS-C at 25°C to late logarithmic phase and then

centrifuged. The resultant pellets were resuspended in 10 ml of sonication buffer (50
mM MOPS, pH 7.0; 1 mM dithiothreitol; 3 mM EDTA). The cells were again
pelleted, resuspended in 1 ml of sonication buffer, and frozen at -80°C. The cells
were immediately thawed, sonicated 5 times at maximum output for 15 sec per burst
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(Bronson sonifier), and allowed to cool on ice between bursts. The sonicated sample
was centrifuged at 68000g for 20 min to remove cellular debris. The resulting
supernatant was the crude lysate used in both mutase assays and was stored at -80°C
until required. Protein concentration of the crude lysates were determined in
triplicate with a standard microtitre Bradford reagent assay (Sigma). This consisted
of 10 pi of sample and 200 pi of Bradford reagent. OD of the samples were
determined at a wavelength of 595 nm using a SpectraMax microtitre plate reader.

Phosphoglucomutase (PGM) and Phosphomannomutase (PMM) activities were
determined essentially as previously described (Koplin et al, 1992; Sandlin and
Stein, 1994). The PGM (Table 2.6) and PMM (Table 2.7) activity assays were
performed in a microtitre plate, where the increase in OD at 340 nm was measured
for 15 min at 25°C. A reaction mix that did not contain cell lysate served as the
negative control, whereas reactions containing commercially available purified PGM
were the positive control for PGM assays. Purified PMM was not available for use
as positive control in PMM assays. Specific activities were expressed as milliunits
per milligram of protein, where 1 pmol of NADP (substrate) is reduced to NADPH
(product) in 1 min by 1 unit (U) of enzyme. NADPH production was calculated
from its molar extinction coefficient of 6220. Lysates were tested in duplicate and
three independent lysates were prepared. All chemicals were obtained from Sigma.
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Table 2.6. Components of the phosphoglucomutase activity assay.

Component

Concentration/Amount
(Total, 300 jti)

M O P S (pH 7.6)
Glucose 1,6-diphosphate

100 m M
0.075 m M

MgCl 2

5.1 m M

NADP

0.2 m M

Glucose 6-phosphate dehydrogenase

0.5 U

Cell lysate

130 ul

Glucose 1-phosphate (to start reaction)

3mM

dH20

To 300 ul

Table 2.7. Components of the phosphomannomutase activity assay.

Component

Concentration/Amount
(Total, 300/d)

M O P S (pH 7.6)
Glucose 1,6-diphosphate

100 m M
0.075 m M

MgCl2

30 m M

NADP

1 mM

Mannose 1-phosphate

1 mM

Glucose 6-phosphate dehydrogenase

0.7 U

Phosphoglucose isomerase

1.1 U

Phosphomannose isomerase

0.9 U

Cell lysate (to start reaction)

130 ul

dH20

To 300 ^1
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2.3.12. Lipopolysaccharide extraction

A simple yet efficient procedure was developed for the extraction of B.
bronchiseptica LPS. Cells were grown to late log phase in SS-C at 25°C or SS-X at

37°C to an A560 of 1.0, and concentrated to A56o 1.5 in PBS. The resultant cell pell
from 500 pi of sample was resuspended in 100 pi dH20. An equal volume of 2X
sample buffer (6% SDS; 6% 2-mercaptoethanol; 10 mM DTT; 46% glycerol; 60 mM
Tris, pH 8.0; 0.1% bromophenol blue) was added and the samples boiled for 10 min.
Protein was digested by the addition of proteinase K to a final concentration of 50
ug.ml"1 at 37°C overnight. Samples were again boiled for 10 min and a second

volume of proteinase K, equal to the first, was added and incubated at 55°C for 3 h.
LPS samples were stored at -20°C until required.

2.3.13. Electrophoresis of lipopolysaccharide

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis (TSDS PAGE)
was used to obtain high resolution of LPS. Gels were assembled as a two-phase gel
with a 16.5%) resolving component overlaid with a 4% stacking component.
Electrophoresis was performed as previously described (Lesse et al, 1990). The
acrylamide concentrations of the two phases was 49.5%> T, 6% C and 49.5%) T, 3% C
respectively, where T represents the total acrylamide percentage (acrylamide and

bisacrylamide), and C is the percentage of bisacrylamide (cross linker). All solution
were prepared with high quality milli Q water (Millipore). This system utilises two

specific buffers for electrophoresis, ie. anode buffer (0.2 M Tris, pH8.9) and catho
buffer (0.1 M Tris, 0.1 M tricine, 0.1% SDS, pH 8.25). Electrophoresis was

Experimental Procedures

57

performed with the BioRad Mini-Protean II gel apparatus (BioRad), with the glass
plates being thoroughly washed with 20% Decon 90 and rinsed well with milli Q
water. Prior to loading, the LPS samples, together with loading dye, were boiled for
5 min. Samples were loaded under cathode buffer and electrophoresed for 5 h or
until 1 h after the dye front had reached the end of the gel.

LPS was visualised by oxidative silver staining (Tsai and Frasch, 1982). Following
electrophoresis the gels were fixed overnight in a 40% ethanol, 5% acetic acid
solution in a thoroughly washed and rinsed glass dish. The fixing solution was
replaced with 0.7%> periodic acid in 40%> ethanol, 5% acetic acid and allowed to
oxidise for 7-10 min. The gels were washed 3 times for 15 min with 200 ml milli Q
water. After washing, the gels were stained with fresh silver staining reagent,
containing 2 ml concentrated ammonium hydroxide, 28 ml of 0.1 M NaOH, 5 ml of
20% (w/v) silver nitrate, and milli Q water to 150 ml. The staining solution was left
on for 10 min before being removed and the gels undergoing 3, 10 min washes with
milli Q water. Once washed the stained gels were developed by the addition of 200
ml of developer, containing 10 mg citric acid and 100 pi of 37% formaldehyde. As
the stain neared the desired intensity the development was terminated by replacing
the development solution with water or a mild acidic solution.

2.3.14. Resistance to oxidative stress

A disk diffusion assay was utilised to determine sensitivity to paraquat (methyl
viologen; Sigma) (Jungnitz et al, 1998). Approximately lxlO6 cells of BB7865
BB7866, BB7%65pgm, and BB7866^gm were plated onto SS-X or SS-C. A filter
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with a 0.22 p m pore size, presoaked in 10 m M paraquat, was placed onto each plate
followed by incubation at 30°C or 37°C until bacterial growth was obvious.

Sensitivity to paraquat was measured by the zone of inhibition surrounding the disk
The zone was measured in two axes and the mean values calculated.

2.3.15. Superoxide dismutase (SOD) assays

For SOD assays, sonicated cell samples (100%) output, 4 x 15 sec bursts) were
cleared by centrifugation (12000g for 2 min). 115 pg of protein from each sample
was loaded onto a 8 % native polyacrylamide gel and electrophoresed according to
standard procedures (Westermeier, 1993). Nitroblue tetrazolium (NBT) was used to
reveal regions of enzyme activity as outlined by Beauchamp and Fridovich (1971).
The gels containing samples with possible SOD activity were immersed in a 2.45
mM NBT solution for 20 min. The gels were then transferred to a solution
containing 28 mM TEMED, 2.8 x 10"2 mM riboflavin, and 36 mM potassium
phosphate (pH 7.8) for 15 min. Following this incubation, the gels were placed in

small, clean, sealable plastic bags and illuminated for 5-15 min on a fluorescent li
box. At this stage the gels became uniformly blue, apart from regions where SOD
was localised. Gels were photographed when maximum contrast between the
background blue colour of the gel and the lighter achromatic regions (Beauchamp
and Fridovich, 1971).

Experimental Procedures

59

2.3.16. Acid phosphatase assay

The procedure for determining acid phosphatase activity made use of a plate assay.
Strains to be tested were grown on BG medium until single colonies were evident.
Single colonies were resuspended in sterile physiological saline (0.7%) and spotted

in 5 pi aliquots onto either SS-X (for incubation at 37°C) or SS-C (for incubation at
30°C) plates containing 50 pg.ml"1 Xp. Following incubation, plates were examined
and photographed. Blue growth denotes acid phosphatase activity.

2.3.17. Cecropin P radial diffusion and liquid killing assays

The sensitivity of the pgm mutant strains to cecropin P, a bioreactive peptide, was
tested. Radial diffusion assays were performed essentially as described previously
(Banemann et al, 1998). Bacteria were cultured on BG agar before being
resuspended to a final OD of 0.2 at A6oo in SS medium. Low gelling temperature
agarose (1%>) in either SS-X or SS-C was prepared and when cool was supplemented
with bovine serum albumin (final concentration 0.15%). To 10 ml aliquots, 200 pi
of the cell suspensions were added and allowed to set in a standard 90 mm petri dish.
5 pg of cecropin P (sigma) (1 pg.pl"1 in H20) was added to 3 mm diameter holes
made in the agarose. Following incubation at room temperature for 4 h, the plates
were transferred to 37°C (SS-X plates) until zones were clearly visible. For liquid
killing assays, BB7865 and BB7S65pgm were cultured on SS-X at 37°C and
suspended in phosphate buffered saline. Equal volumes of the cell suspension and
cecropin P were combined giving a final peptide concentration of 50 pg.ml .

Experimental Procedures

60

Following 1.5 h incubation at 37°C, serial dilutions performed on BB7865,
BB7865/>gm, with and without cecropin P, were plated onto SS-X.

2.3.18. Tissue culture

For in vitro tissue culture experiments, assistance was received from Carlos Guzman
and Heidi Jungnitz of the National Research Centre for Biotechnology-GBF,
Germany. HeLa cells (American Type Culture Collection CCL2, Rockville, MD),
J774.A1 cells, and the mouse dendritic cell line CB1 were maintained in Dulbecco's
modified Eagle medium (DMEM) supplemented with 10% foetal calf serum (v/v)
and 5 mM glutamine in an atmosphere containing C02 (5%>, v/v) at 37°C.
Approximately 5 x 104 cells were seeded per well in 24-well tissue culture plates,
incubated for 18 h, and then washed twice with complete medium. For invasion
assays, B. bronchiseptica was cultured on BG agar for 24 h, and suspended in
complete DMEM to an OD540 nm which corresponded to approximately 4 x 107
CFU.ml"1. 500 pi of cell suspension was added to each well of the tissue culture
plate, containing the eukaryotic cells, and incubated without agitation at 37°C for
h. In order to remove non-adherent bacteria, all fluid was removed and the cell
washed twice with PBS. Complete DMEM (500 pi), containing 100 pg.ml"1
gentamicin was added to the cells and the plates incubated at 37°C for 2 h to kill

remaining extracellular bacteria. Prior to lysing the eukaryote cells by the additio
of 500 pi dH20, residual gentamicin was removed by twice rinsing the plates with
PBS. The number of CFU recovered was determined by plating 10 fold dilutions
onto BG agar using a Spiral Plater model C (Spiral Biotech, USA). The results
reported are mean values of three independent assays with standard deviations.
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Incubation of B. bronchiseptica bacteria suspended to a density equal to that used in
the invasion assays in DMEM supplemented with gentamicin at 100 pg.ml-1 for 2 h
resulted in greater than 6 orders of magnitude reduction in CFU. The results obtained
were subjected to analysis of variance and Student's t-test. Differences were
considered significant at P 0.05.

2.3.19. Murine respiratory infection model

Female BALB/c mice at 6-10 weeks of age were used as a model of in vivo
respiratory infection by B. bronchiseptica. Following an intraperitoneal treatment
with Ketamine 50 mg.kg"1 and Xylazine 10 mg.kg"1 in sterile PBS, two 12.5 pi
aliquots of a bacterial suspension was delivered intranasally using an airdisplacement pipette and the mouse was allowed to recover. The total number of
viable bacteria administered was approximately lxl05 cells. At each time point, four
mice from each group were sacrificed and their lungs removed aseptically. Lungs
were homogenised in sterile physiological saline and appropriate dilutions were
plated onto nutrient agar to determine the number of viable bacteria present in the
lungs.

2.3.20. Enzyme linked immunosorbent assay (ELISA)

2.3.20.1. Whole cell coating of ELISA plates
B. bronchiseptica was grown to late log phase in SS-X. The culture was centrifuged
and the pellet resuspended in 0.3% methyl glyoxal (pH 8.0), a binding factor which
allows for the omission of centrifuging the bacteria onto the ELISA plate
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The mechanism by which methyl glyoxal mediates

attachment of the bacteria to the ELISA plates is thought to be due to cross linking
proteins exposed on the bacterial surface and the polystyrene plate (Peters and
Richards, 1977). The culture was resuspended to an OD56o of 0.8. The addition of

50 pi of this solution to each well in the plate was considered to deliver 5 x 107 ce
This number of bacteria is estimated to yield an even and homogenous coverage
(Elder et al, 1982). The plates were then incubated for 2 h at 37°C, washed, dried
and stored at 4°C until required.

2.3.20.2. Immunosorbent assay
Non-specific binding was blocked by the addition of 200 pi PBS containing 0.5%
BSA and 0.05% Tween 20 (v/v) and incubating the plates at 37°C for 60 min. The
plates were washed 4 times with 1 x PBS containing 0.1 %> Triton X-100 before the
addition of various starting concentrations of mouse serum antibodies or lung wash
antibodies. These antibodies were 2-fold titrated down the plates, which were then
incubated at 37°C for 60 min. Following incubation the plates were washed as
before and the second antibodies administered. The second antibodies were
horseradish peroxidase (HRP) conjugated IgG (1:2000) or IgM (1:2000), for serum
antibodies, and IgA (1:4000) for lung wash antibodies. The plates were again
incubated at 37°C for 60 min. Following incubation the plates were washed as
before and the bound HRP conjugate was detected by the addition to each well of
100 pi of o-phenylenediamine (OPD) reagent (2.5 mg OPD and 1 pi 30% H202 per
ml in ELISA citrate buffer). The reaction was stopped by the addition of 50 pi 1 M
HC1 after 7 min. The plates were read in a SpectraMax plate reader at 490 nm.
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RESULTS I

3.1. Generation and Characterisation of Motility Mutants of B. bronchiseptica.

3.1.1. Introduction

Prokaryotic flagella are subcellular organelles that originate in the membrane of the
cell and extend approximately 15 - 20 pm from the bacterial surface. They are
reversible rotary devices, driven by proton-motive force, and are responsible for
bacterial motility and chemotaxis (Macnab and Parkinson, 1991; Silverman and
Simon, 1977).

Bacterial flagella are composed of three morphologically distinct structures, which

are illustrated in Figure 3.1. These are the basal structure, the hook, and the filament
Although the basal structure accounts for only 1% of the mass of the complete
organelle, it is the most complex component. The hook is located at the base of the
flagella filament and is thought to behave as a "universal joint" which allows
effective transference of rotational motion to the rest of the structure. The hook is
also the initiation point for the growth of the filament (Masten and Joys, 1993;
Schoenhals and Whitfield, 1993; Silverman and Simon, 1977). The filament consists
of a single protein subunit known as flagellin. The flagellin protein accounts for
98%> of the mass of bacterial flagella.
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Figure 3.1. Schematic illustration of the flagella basal body, hook and filament of Escherichia coli
(Alberts^ al, 1989).

The basal structure is composed of four main rings, which anchor the flagella to the
cell wall, thus providing a solid support against which force can be exerted. The
outer membrane rings have been assigned the names L-ring for the outermost ring,
and P-ring for the innermost ring. The two inner membrane rings are known as the
M ring and S ring (DePamphilis and Adler, 1971) (not shown in Figure 3.1). The

proteins that comprise the force generating units that rotate the flagella are locate
within the basal structure (Macnab and Parkinson, 1991).

Formation of prokaryotic flagella and the accompanying array of chemotaxis
receptors and transducers represent a major commitment of resources and energy for
a bacterial cell undergoing development. For this reason they are subject to many
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levels of regulation. Expression of genes for biosynthesis occurs as a complex
transcriptional cascade (Hermann, 1991). This regulatory hierarchy ensures that
flagellin is synthesised only after a pre-requisite set of structural proteins have been
expressed and properly assembled (Kutsukake et al, 1990).

Before investigating the genetic characteristics of flagella genes, an understanding of
the nomenclature of these genes is important. The nomenclature used here follows
the unified flagella gene symbols for Salmonella typhimurium and E. coli established
by various authors (lino et al, 1988).

3.1.1.1. Transcription
Recent evidence supports the existence of a unique a subunit, which is employed by
many bacteria to control transcription of flagella. This modification of the
transcriptional specificity of RNA polymerase by the production of exclusive a
factors provides an effective method for global modulation of gene expression. The
need for a refined a factor to activate transcription of flagellin is a part of the
mechanism for ensuring that the energetically costly expression of flagellin, in cells
that are unable to incorporate flagellin protein into a functional flagellum, will be
avoided (Hermann, 1991).

The present model for flagella gene regulation has arisen from studies with E. coli
and S. typhimurium. Almost 50 genes, grouped into three distinct chromosomal loci
and divided into three different transcriptional activity classes, form the flagella
regulon of these bacteria. Class I includes genes which encode positive activators of
flagella gene expression (Komeda et al, 1975). Class II contains genes for the basal
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body and the flagellin specific export pathway. Class II also contains the fliA gene,
which encodes for the flagella-specific sigma factor, which is responsible for
transcribing genes of Class III. Class III genes encode filament structural proteins
(Doll and Frankel, 1993; Kutsukake et al, 1990). Operons containing genes of the
three classes are illustrated in Figure 3.2.

3.1.1.2. Regulation
Expression of the flagella components is highly regulated (Komeda, 1986). Cells
that lack functional basal body, hook, or switch proteins, encoded by the flhC and
flhD will not transcribe any flagella genes (Komeda and lino, 1979) due to the
regulatory role that they play. BvgAS negatively controls the production of flagella
and the motility phenotype in B. bronchiseptica.

Class I Class II Class III
flgA (1) flgK (2)

flhD (2)

flgB (9)
flhB (3)
fliA (1)
*~fliE (1)
fliF (6)
fliL (7)

fliD (3)
fliC (1)
mot A (4)
• trg (1)
tar (6)
tsr (1)

Total Genes 2 28 18

Figure 3.2. The three classes of flagella genes and the order of gene transcription from E. coli. The
arrows indicate the hierarchy of gene expression. The number after each gene represents the number
of genes in each operon (Helmann, 1991).

The frl gene from B. bronchiseptica is considered

homologous to the E. coli class I gene,flh belonging to the flhD locus (Akerley et al, 1995).
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A gene encoding a negative regulator of flagellin synthesis has also been identified in
S. typhimurium (Gillen and Hughes, 1991). It is evidently responsible for the
coupling of flagellin expression to complete flagella assembly by obstructing
expression of the flagellin genes when a constituent of Class II proteins is faulty.
This component has been identified as flgM (Gillen and Hughes, 1991). When flgM
is insertionally inactivated, expression of the flagellin gene is resumed. Caulobacter
crescentus controls motility by an unknown coupling mechanism between spatially
organised gene expression and cell cycle-dependant synthesis of flagella (Akerley
and Miller, 1993). Control of a great number of structural genes by a small number
of key regulatory factors represents a common theme of such bacterial systems.

Two distinct flagellin species have been isolated from two individual B.
bronchiseptica strains. These strains, GP1SN and BB7865 possess flagella with
reported subunit sizes of 40 and 35 kDa respectively. Amino acid sequence data
shows 100%) homology in the N-terminal region however these isotypes are not
reported to be co-expressed (Akerley et al, 1992).

The role of many 6vg-activated genes in virulence is undisputed, however the
contribution by &vg-repressed genes to virulence is yet to be determined. B.
bronchiseptica has the ability to invade and survive in several mammalian cell lines
in vitro, including epithelial cells (Schipper et al, 1994). It is suggested that the
ability of the pathogen to do so is an important factor with regard to virulence,
although whether frvg-repressed phenotypes such as flagella are involved is
uncertain. Ectopic expression of flagella in B. bronchiseptica (during frvg-activated
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phase) results in a decreased ability to colonise the rat trachea (Akerley et al, 1995).
It is also suggested that the lack of antibodies reactive against vrg products in wild
type infections demonstrate that these molecules are not needed during infection.
Other evidence would suggest that these gene products are utilised, as was described
by Akerley et al (1992), where the recovery of antibodies against flagella following
infection of guinea pigs was described.

3.1.2. Chapter aims

The aims for the current chapter are to investigate the influence of motility of B.
bronchiseptica during colonisation and survival within eukaryote cells by utilising
motility mutants. Motility mutants were to be constructed from the virulent B.
bronchiseptica strain BB7865 and the avirulent strain BB7866. Once constructed,
the mutants would be characterised by phenotypic and genetic means such as western
blotting and southern hybridisation. Mutants will also be characterised as to their
ability to invade and survive within a eukaryotic cell lines (HeLa) and mouse
dendritic cells.

3.1.3. Isolation of motility mutants

Following mutagenesis utilising the mini-Tn5 lacZl mini-transposon (Figure 2.1),
four non-motile mutants (designated AMM1-4) were isolated from the isogenic bvgnegative B. bronchiseptica strain, BB7866 and one from the 6vg-positive strain,
BB7865 (designated VMM1). BB7866 has been locked into the 6vg-negative phase
due to a deletion in bvgS, the sensor component of the Bvg locus. This strain
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constitutively produces flagella and is capable of motility, regardless of growth
condition. Surprisingly, one of these mutants, A M M 4 , was found to regain partial
motility at 25°C following growth in the modulating medium, SS-C or the nonmodulating medium, SS-X (Figure 3.3).

Figure 3.3.

SS-C, 25 °C

SS-C, 37 °C

SS-X, 25 °C

SS-X, 37 °C

Mutation of B. bronchiseptica B B 7 8 6 6 and B B 7 8 6 5 , and the resultant motility

phenotypes. Motility assays were conducted in 0.4% (w/v) semi-solid agar media. Motile bacteria
migrate outwardly from the stab inoculation site during growth. M e d i u m and growth conditions are as
indicated and positions of inoculations and strains are shown in the key provided. O f interest is the
observed loss of motility for A M M 4 only at 37°C.
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This type of differential expression of motility is normally only observed from the
wild type 6vg-positive strain, B B 7 8 6 5 . Confirmation of successful integration of the
mini-transposon into the chromosome w a s achieved by Southern hybridisation
(Figure 3.4). The presence of the transposon in the EcoRI restricted chromosomal
D N A of the strains w a s revealed by utilising pUT::mini-Tn5 lacZl as the probe.

Figure 3.4. Southern hybridisation analysis of EcoKl digests of chromosomal D N A isolated from B.
bronchiseptica BB7866, BB7865, and their respective mutants hybridised to p U T mini-TnJ lacZl.
Lane 1, BB7865; lane 2, BB7866; lane 3, A M M 4 ; lane 4, A M M 1 ; lane 5, A M M 2 ; lane 6, A M M 3 ;
and lane 7, V M M 1 . XHinAlW D N A standards are indicated to the left.

3.1.4. Invasion and Intracellular survival ofB. bronchiseptica motility mutants in
mouse dendritic cells and the HeLa epithelial cell line

To characterise the role of flagella in eukaryotic cell invasion, the ability of the
motile mutants to invade (after 4 h) and survive in (after 24 h) H e L a cells (Figure
3.5A) w a s examined.

The non-motile mutant A M M 3

did not demonstrate a
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significantly altered ability for invasion and survival when compared to BB7866.
However, AMM4, which only displayed motility at reduced growth temperatures,
exhibited significantly decreased invasion and survival capabilities in HeLa cells.
The insertion mutation responsible for the AMM4 phenotype seemed to result in the
re-establishment of temperature control over the expression of motility. The nonmotile mutants AMM1 and AMM2 generally showed reduced ability to invade and
survive in HeLa cells, however only the measurement for AMM2 at 4 h showed a
significant decrease in % CFU recovered. The frvg-positive mutant, VMM1
displayed a significantly improved ability to both invade and survive within HeLa
cells as compared to BB7865.

The ability of the mutants to invade and survive in mouse dendritic cells was also
assessed (Figure 3.5B). The numbers of intracellular parental bacteria (both BB7865
and BB7866) after 4 h and 24 h were much higher for dendritic cells when compared

with HeLa cells, which may reflect the macropinocytosis ability of the dendritic cell
line CB1. Once again, AMM4 showed a significantly reduced ability to invade and
survive in dendritic cells, as did AMM1 and VMM1 after 24 h.
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Figure 3.5. Intracellular survival of B. bronchiseptica strains at 4 and 24 h within H e L a cells (A) and
the mouse dendritic cell line C B 1 (B). Results shown for A M M 1 - 4 and V M M 1 are represented as the
mean percentages of C F U recovered per well of the respective parental strain, ie. BB7866 and
BB7865 (100%). Actual mean values of the C F U per well recovered from the parental strains in
HeLa cells at 4 h and 24 h were 1050 and 396 respectively for BB7866, and 17662 and 27694 for
BB7865. For dendritic cells the values were 1.8 x 1 0 6 and 1.2 x 1 0 6 C F U per well of BB7866 at 4 h
and 24 h respectively, and 1.4 x 10^ and 9.9 x 10^ for BB7865.

Error bars indicate standard

deviations. Variation between the parental strains and their mutant derivatives were considered
significant ati>0.05 (*); andPO.001 (**).
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3.1.5. Identification of flagella biosynthesis via western blot analysis

In order to establish a relationship between loss of motility and flagella structure,
western hybridisation was employed utilising flagella (BB7866 purified) specific,
cross-absorbed, rabbit polyclonal antibodies. These blots revealed a 40 kDa protein
which reacted specifically in whole cell extracts of BB7865 and BB7866 (Figure 3.6,
Lanes 1 & 3). As expected, flagellin expression by the 6vg-positive parental strain
BB7865 was repressed by the absence of MgS04 and growth at higher temperatures
(Figure 3.6, lane 1), whereas the 6vg-negative parental strain BB7866 and the mutant
AMM3 expressed flagellin under all conditions tested (Figure 3.6, lane 3 & 6
respectively). The mutants VMM1, AMM1 and AMM2 did not express detectable
levels of flagellin under any of the growth conditions tested (Figure 3.6, lanes 1,4
and 5 respectively). Interestingly, the fcvg-negative mutant strain AMM4 exhibited
temperature-dependant repression of flagellin expression in both the presence and
absence of MgS04 (Figure 3.6, lane 7). This discovery was particularly surprising
considering that this mutant was derived from a strain devoid of the ability to
modulate the expression of 6vg-negative phenotypes. The mechanism by which
AMM4 represses the production of functional flagella in a seemingly temperature
dependant fashion was of further interest and hence became the main focus of this
study.
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Figure 3.6. Western blot analysis of B. bronchiseptica parental strains and their respective mutants
hybridised to rabbit polyclonal anti-flagella anti-serum. Blots were performed on cells grown in the
presence (SS-C) and absence (SS-X) of M g S 0 4 at 25° C and 37° C. Lane 1 contains BB7865; lane 2,
V M M 1 ; lane 3, BB7866; lane 4, A M M 1 ; lane 5, A M M 2 ; lane 6, A M M 3 ; lane 1, A M M 4 ; and lane 8
contains purified flagella obtained from BB7866. Arrows indicate the 40 k D aflagellinprotein.
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RESULTS II
LIPOPOLYSACCHARIDE AND PHOSPHOGLUCOMUTASE

4.1. Lipopolysaccharide

4.1.1. Introduction

Lipopolysaccharide (LPS) is a highly toxic and immunogenic molecule that
constitutes a major component of the cell membranes of Gram-negative bacteria.
LPS has now emerged as having an integral role in the infection process, being

responsible for resistance to serum, antibiotics (Rietschel et al, 1994), and naturally
occurring antimicrobial peptides termed defensins (Banemann et al, 1998). The role
of LPS in determining host specificity and as an important adhesin molecule also
seems likely; however, its mode of action still remains largely unknown. It has

recently been described that the LPS of some strains of B. bronchiseptica is regulated
by the bvg system (van den Akker, 1998).

4.1.2. LPS Structure

The characteristic structure of LPS from a wide range of Gram-negative bacteria
consists of three individual domains. These are known as Lipid A, the membrane
component; core, a non-repeating oligosaccharide; and an O-antigen consisting of a
distinct repeating oligosaccharide (Figure 4.1).

Results

77

O-antigen

Core sugars
Lipid A
Phospholipids

•>. ,-•>. r~. r
i> i> V

r Outer membrane

Figure 4.1. Generalised structure of LPS. O-antigen, core sugars, and outer membrane components
are indicated.

Considerable variation exists between the glycolipid structures of the Genus
Bordetella (van den Akker, 1998). The L P S of B. pertussis displays a structure that
generally typifies that of non-enteric bacteria and is the simplest of the Bordetellae.
This consists of a Lipid A region anchored in the cell membrane which is a
polyacylated and phosphorylated disaccharide of glucosamine (Raetz, 1993). This is
linked to a branched oligosaccharide domain constituting the core, by a single ketodeoxyoctulosonic acid ( K D O ) (Allen and Maskell, 1996; Gueirard et al, 1998). The
core consists of heptose (Hep), glucose (Glc), glucuronic acid (GlcA), glucosamine
(GlcN), and galactosaminuronic acid (GalNAcA), with the last three molecules all
being charged and all are not commonly found as components of other L P S core
molecules (Caroff et al, 1990; Lasfargues et al, 1993; Lebbar et al, 1994). These
glycolipids lack long repeating oligosaccharide units as are found in
Enterobacteriaceae and are therefore sometimes termed lipooligosaccharides (Preston
et al, 1996). B. bronchiseptica and B. parapertussis do however produce an Oantigen of a single sugar polymer, consisting of 2,3-dideoxy-2,3-di-/V-
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acetylgalactosaminuronic acid (2,3-diNAcGalA) (Di Fabio et al, 1992).
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A

schematic representation of the LPS from B. bronchiseptica is seen in Figure 4.2.

Two distinct bands, ie. band A and band B (Peppier, 1984) are evident upon
electrophoresis of purified B. pertussis LPS. Band B consists of the core region of
the molecule, whereas the slower migrating band A is this same core with the
addition of a distal trisaccharide comprised of A^-acetylglucosamine, A^-acetyl-A'methylfucosamine, and 2,3-di-deoxy-2,3-di-A/-acetylmannosaminuronic acid (Figure
4.2) (Allen and Maskell, 1996). This addition to the core molecule does not occur in
B. parapertussis. It is understood that the presence of all three components of the
LPS molecule, ie. lipid A, core, and O-antigen are required for virulence of E. coli
(Kadrmas andRaetz, 1998).
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Figure 4.2. Proposed schematic representation of the major L P S species from B. bronchiseptica
based upon current knowledge. Lipid A is shown in blue, the core structure in red, and the O-antigen
in green. (Zarrouk et al, 1997). Abbreviations: K D O , keto-deoctulosonic acid; Hep, heptose; G l c A
glucuronic acid, GlcN, glucosamine, F u c N A c M e , Af-acetyl-AZ-methylfucosamine; N a c M a n A Nacetylmannosaminuronic acid; GlcNAc, TV-acetylglucosamine; G a l N A galactosaminuronic acid;
N A c G a l A iV-acetylgalactosaminuronic acid.
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4.1.3. Lipopolysaccharide Genetics

A distinguishing factor of LPS in regard to its genetics is that it is a tertiary gene
product. A primary gene product is one in which its structure is determined directly
from the original gene sequence, for example RNA, a nucleic acid. A secondary
gene product can be thought of as one in which its structure is fashioned by the
organisation of nucleic acids, ie proteins. Finally proteins will then determine the
structure of LPS. This process is heavily reliant on the specificity of enzymes to
effect the synthesis of, and the linkage together, of the correct components. The
synthesis of different parts of the LPS molecule are produced independently, utilising
unique precursors, cofactors, and transporters, possibly even from distinct locations,
being assembled into the completed molecule as the last stage (Makela and Stacker,
1984).

Large gene clusters for LPS production in B. pertussis and B. bronchiseptica have
been identified. The first described a locus of approximately 16.5 kb containing 14
open reading frames (ORF) which have been described as required for LPS
biosynthesis in B. pertussis, predominantly involved with the production of core
molecules including the band A trisaccharide (Figure 4.3) (Allen and Maskell, 1996).
Virtually identical loci have been identified in B. bronchiseptica and B.
parapertussis, however as stated earlier, B. parapertussis does not express band A.
In addition, the band B of this species does not react with monoclonal antibodies
(mAbs) specific for B. pertussis band B, suggesting structural differences. Band B
from B. bronchiseptica will react with the B. pertussis mAbs but only when the
bacteria are in the vir repressed phase (Martin et al, 1992).
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Figure 4.3. The wlb locus (LPS band A biosynthesis locus) found in B. bronchiseptica, B. pertussis,
and B. parapertussis. Included are waaA ( K D O transferase) and waaC

(heptosyltransferase), genes

for deep inner core biosynthesis, and baf (Bvg accessory factor). Individual genes are separated into
reading frames as indicated. Increments are 1000 bp.

Deletion of the entire wlb locus prevented the biosynthesis of band A in B.
bronchiseptica and B. pertussis, however band B production was unaffected in each
of the three species. Loss of O-antigen from B. bronchiseptica and B. parapertussis
was also observed in the mutant strains (Allen et al, 1998a). This same study
demonstrated that the introduction of the wild type wlb loci from either B.
bronchiseptica of B. pertussis into the B. parapertussis wlb mutant enabled the
expression of band A. This suggests that there are some similarities between the core
structures of these species, at least as far as an attachment point for band A
trisaccharide. Also interesting was the finding that the B. bronchiseptica wlb mutant,
when complemented with wlb from B. parapertussis, regained the ability to
synthesise an O-antigen but was unable to generate band A. The regulation of this
locus will be discussed below.

Results

82

A large locus that is required for O-antigen biosynthesis has recently been identified
in B, bronchiseptica and B. parapertussis (Preston et al, 1999). The locus is
approximately 27 kb and contains 21 ORFs (Figure 4.4).

Figure 4.4. The wbm

locus (O-antigen biosynthesis locus) found in B. bronchiseptica and B.

parapertussis. Individual genes are separated into reading frames as indicated. Increments are 1000
bp.

Mutation of this locus in B. bronchiseptica results in an O-antigen deficient strain,

although it is unknown whether the entire locus is required for successful expression.
Putative functions have been assigned to many of the ORF of the wbm locus due to
sequence similarities, ranging from modifying enzymes and carbohydrate
transferases to membrane bound O-antigen exporters (Preston et al, 1999). The wlbband A trisaccharide biosynthesis locus (Figure 4.3) and the w6w-0-antigen
biosynthesis locus (Figure 4.4), are spatially consecutive in B. bronchiseptica hence
the successive numbering of gene positions between the two figures. The wbm locus
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is absent from the B. pertussis genome being replaced by an insertion sequence. The
underlying mechanism as to why B. pertussis lacks O-antigen is obvious, however
the reasons why this molecule is not required by the species are speculative.

4.1.3.1. Inner core biosynthetic genes
The genetic basis for much of the LPS molecule of B. bronchiseptica has only
recently been identified. However the genetics of the deep inner core still evade
discovery and hence have been the recent focus of a great deal of work. Four
molecules can be considered as constituting the inner core, these being, ketodeoctulosonic acid (KDO), 2 heptose molecules, and glucose.

4.1.3.2. waaA
The gene waaA is 1287 bp in length and has been identified as having extensive
amino acid homology with the KDO transferase of E. coli, encoded in this species by
kdtA. The KDO transferase of E. coli is responsible for the addition of KDO to the
lipid A precursor, lipid IVA (Raetz, 1993). High amino acid homology is evident
across the entire length of these proteins from B. pertussis, Haemophilus influenzae,
E. coli and that of Chlamydia spp. (Allen and Maskell, 1996; Clementz and Raetz,
1991; Fleischmann et al, 1995). WaaA is not incorporated into the wlb locus but is
considered divergent from it (Figure 4.3).
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4.1.3.3. waaC
The gene waaC is 1008 bp in length and is located directly upstream of waaA (Figure
4.3). The protein encoded by waaC shares high homology with the products of a
gene identified in a number of bacteria known as rfaC (Sirisena et al, 1992; Zhou et
al, 1994). Encoded by rfaC is a glycosyltransferase that initiates the transfer of the
first heptose residue to KDO. waaA and waaC are spatially juxtaposed, being
separated by a single basepair and are therefore thought to constitute an operon that
may be translationally coupled (Allen and Maskell, 1996). This arrangement appears
to be unique to Bordetella as kdtA and rfaC are transcribed separately in other known
systems.

4.1.3.4. waaF
A gene responsible for the transfer of the second heptose residue to the core
molecule has been identified in Bordetella and designated waaF. This gene encodes
a protein with amino acid sequence similarity to heptosyltransferase II found in other
Gram-negative bacteria (Allen et al, 1998b).

The genes responsible for the biosynthesis or addition of the final residue of the inne
core, ie. glucose, have previously eluded discovery. This study has uncovered a gene
vital for inner core biosynthesis and hence the entire distal portion of the molecule,
including band A trisaccharide and O-antigen. The gene has been identified as
phosphoglucomutase and will be discussed in detail later. Mutation of this gene
constitutes the most minimal LPS structure capable of maintaining viability.
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4.1.4. Lipopolysaccharide function

The functions of LPS in Gram-negative bacteria are many and varied. These range

from maintaining the structural integrity of the cell membrane, to initiating infection,
to intracellular survival. In Gram-negative bacteria, all components of LPS are
required for virulence (Allen and Maskell, 1996). It is understood that all three
elements of the LPS molecule, ie. lipid A, core, and O-antigen are required for
virulence of E. coli (Kadrmas and Raetz, 1998). Viability of the organism is not
necessarily disrupted by the absence of the O-antigen or several of the core sugars,
but the KDO residues of the core and the lipid A are essential for growth (Kadrmas
and Raetz, 1998). So important is the Lipid A component of LPS to the viability of
the cell that it has been described as a suitable pharmaceutical target (Onishi et al,
1996). Lipid A, is an integral component of the outer leaflet of the outer membrane
of the bacterium. Disruption of Lipid A biosynthesis by way of an inducible
mutation results in a reduction of viability, of several logs, within 4 h (Galloway and
Raetz, 1990). A potent antibacterial agent was developed against E. coli lipid A that
demonstrated dramatic bacterial killing at 1 pg.ml"1, and cured mice infected with a
lethal dose of E. coli (Onishi et al, 1996).

Several lines of evidence suggest that LPS play a part in infection and survival. Host
specificity and adhesion to eukaryotic cells may be two factors by which LPS
influences the early stages of infection. There is extensive variation in LPS
expression between and within the Bordetella species, furthermore this variation
appears to be host species specific (van den Akker, 1998). B. bronchiseptica isolates
from pigs were distinctive to those from dogs as were those from humans (Gueirard
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et al, 1998; L e Blay et al, 1997). Bacterial invasion into H e L a cells was blocked by
mAbs directed against LPS (Ewanowich et al, 1989b). Also, the LPS of Neisseria
gonorrhoeae can promote invasion of host cells by acting as a ligand for human
receptors (Blake et al, 1995), and LPS is known to be the major adhesin of
Actinobacillus pleuropneumoniae for lung tissue (Paradis et al, 1994). This
evidence suggests an adherence capability may exist for Bordetella LPS and as such
is an important factor in infection.

The final aspect of LPS influence on pathogenesis to be considered is one of

intracellular survival. Properties attributed to LPS concerning intracellular survival,
are resistance to host defences such as serum and cationic antimicrobial peptides
known as defensins (Banemann et al, 1998; Rietschel et al, 1994). Defensins may
be encountered in professional phagocytes or during colonisation of the respiratory
tract epithelia. In fact many mucosal surfaces possess this type of innate immunity
and therefore an efficient defence strategy is required even when not exposed to
serum. The highly charged O-antigen is believed to shield the anionic phospholipids
of the bacterial cell, which would otherwise become tightly bound to the cationic
peptide, thereby disrupting the cytoplasmic membrane (Maloy and Kari, 1995). The
lack of an O-antigen is believed to be the explanation as to why B. pertussis is more
susceptible to this kind of peptide (Banemann et al, 1998). A further aspect of
evasion of host immunity is the possibility of molecular mimicry due to the
immunochemical similarity of LPS epitopes and glycosphingolipid antigens which
may be encountered in vivo (Preston et al, 1996).
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To investigate the contribution of motility to the virulence of B. bronchiseptica,
several motility mutants were characterised as to their regulation and ability to
invade and survive in mammalian cell lines. One particular bvg-negative mutant
AMM4, demonstrated temperature dependant repression of motility at 37°C and a
significantly reduced ability to survive in vitro. Upon further investigation of the
gene affected by the mini transposon insertion, it has been identified as being
necessary for the biosynthesis of functional LPS, and designated
phosphoglucomutase (PGM). This strain has therefore been redesignated
BB7866pgra and has undergone biochemical, molecular, and behavioural
characterisation.

4.1.5. Chapter aims

Lipopolysaccharide, being an integral part of the outer membrane of Gram-negative
bacteria, is credited with many key cellular functions. These include serum
resistance, antibiotic resistance and various endotoxic properties such as platelet
aggregation and cytokine activation (Preston et al, 1996; Rietschel et al, 1994). Of
course much of this work has centred around E. coli and other Enterobacteriaceae.
Owing to two recent publications by Allen et al (1998a) and Preston et al (1999)
many of the LPS biosynthesis genes of B. bronchiseptica are now established,
however these papers, and other literature, fail to establish all the genes required for
early inner core biosynthesis. The aims of this chapter are to extensively characterise
the phosphoglucomutase gene of B. bronchiseptica by way of its genetic composition
and organisation. Further to this, its phenotypic contribution to LPS biosynthesis
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will also be investigated, revealing the subsequent influence the L P S of B.
bronchiseptica has on viability and other in vitro assays.

4.1.6. Cloning of the phosphoglucomutase gene

In order to analyse the region of chromosomal DNA disrupted in BB7866pgm by the
mini-transposon insertion, a segment of DNA containing the Km resistant mini-Tn5
transposon (Figure 2.1), was cloned into the cosmid vector pHC79 to yield the
recombinant cosmid designated pNW6 (Figure 4.5). To obtain a clone with a size
more suited to efficient DNA sequencing a Notl fragment of approximately 5.8 kb
harbouring the lacZ gene was first excised from pNW6 and cloned into
pHSG398'A7od'white, generating pNW17. A further reduction in the size of this
plasmid was required, therefore a 2.3 kb BamEI-Hindlll fragment consisting of B.
bronchiseptica DNA upstream of the mini-Tn5 insertion site was cloned into pUC18
and the resultant plasmid designated pNW19. This clone was adequate for the
successful DNA sequencing of the upstream portion of the affected gene, however in
order to sequence the gene in its entirety, ie. downstream of the insertion site,
additional cloning steps were necessary.

DNA sequence data obtained adjacent to the transposon insertion site allowed for the
design and consequent production of PCR primers. These primers enabled the PCR
amplification of a 300 bp gene fragment (Figure 4.6) which was subsequently
utilised to probe a BB7865 cosmid library via colony hybridisation (Figure 4.7).
Positive colonies resulting from the colony hybridisation were then further screened
via Southern blotting for conformation of sequence homologous to the PCR fragment
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(Figure 4.8A). In order to identify a restriction enzyme that would yield a D N A
fragment of suitable size for subcloning, the clone positive for the PCR fragment
probe (pNW23) was digested with a wide array of enzymes and the restriction
fragments were analysed by Southern hybridisation. The restriction enzyme Notl
was selected (Figure 4.8B) and thereafter utilised to subclone the 3.4 kb Notl
fragment of pNW23, thereby generating the recombinant clone designated as pNW24
(Figure 4.5). DNA sequence analysis of pNW24 revealed the presence of a complete
gene (discussed below) with an amino acid sequence identity of 55% (72%
similarity) with phosphoglucomutase (PGM) from Neisseria gonorrhoeae. This
discovery prompted the renaming of AMM4 to BB7866pgm.
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miniTn5-lacZl
trp-LacZ
Bamm

Notl

,-- -J~ -

Notl

Cmr

Not\
ffmdlll

BamHl

Hinmi

1
B

B. bronchiseptica D N A
containing pgm gene

Figure 4.5. F l o w chart representing the major steps involved in cloning of the phosphoglucomutase
gene. Initial subcloning and sequencing of the pgm gene is indicated as Section A.

Section B

represents additional cosmid cloning, colony blots and subcloning (Figure 4.7 and Figure 4.8) required
to attain the portion of the pgm gene downstream of the transposition site. Section C illustrates the
final clone containing the entire pgm gene.
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Figure 4.6. Agarose gel electrophoresis of a 300 bp D N A fragment amplified from the pgm gene of
B. bronchiseptica BB7865. This P C R product was utilised as a D N A probe in cloning experiments.
Lane 1 contains XHindlll D N A standards, Lane 2 contains the P C R product, PCR-1.

Figure 4.7. Autoradiogram of the colony blot arising from the cosmid cloning experiments utilised to
clone thepgm gene of B. bronchiseptica. The blot was probed with the 300 bp P C R fragment excised
from p N W - P C R l , which was also included as positive control and is indicated by the red arrow. A
single positive clone was apparent from these experiments and is highlighted by the red circle.

Results

92

A

B
1 2

3 4

1 2

s3 s4

s2

m

3.19.46.64.32.32.0-

Figure 4.8.

Subcloning of putative phosphoglucomutase positive cosmids, cloned via colony

hybridisation. (A) Agarose gel electrophoresis and Southern blot results of 2 cosmid clones from
colony blot, as seen in Figure 4.7. Lanes 3 and 4 show the agarose electrophoresis of the

BamHl

digested chromosomal D N A from 2 clones obtained from the aforementioned colony blot. XHindRI
D N A standards with sizes indicated at left were electrophoresed in lane 1 and p N W - P C R l was
electrophoresed in lane 2 as a positive control. Lanes s3 and s4 depict the Southern blot of the
equivalent lanes. (B) Demonstration of the Notl digestion of the pgm positive clone (lane 2) arising
from the colony blots. Southern blot analysis identified a fragment size of approximately 3.4 kb (lane
s2). D N A standards were electrophoresed in lane 1.

4.2. Molecular Analysis of the Phosphoglucomutase Locus of B. bronchiseptica

4.2.1 Identification of a novel LPS genetic locus in B. bronchiseptica

4.2.1.1 DNA

sequence analysis of the PGM

operon

The plasmid p N W 2 4 contains the complete P G M gene.

The entire gene was

sequenced in both directions to account for any spurious sequencing errors that m a y
have been introduced (Figure 4.9A). Separated by just 10 base pairs and downstream
of the P G M encoding gene, a second open reading frame was identified which
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exhibits high homology with the phosphoglucose isomerase (PGI) gene from several
organisms. Analysis of the plasmid pNW24 yielded an uninterrupted contiguous
sequence measuring approximately 3.2 kb. These sequence data are depicted in
Figure 4.9B and have been submitted to the GenBank database under the accession
number AF171632.

The mini-Tn5 transposition therefore mutated a pgm like gene in B. bronchiseptica
BB7865. This gene is required for the early stages in the biosynthesis of LPS in
several species. Investigation of this gene product, and the effect of the mutation on
several important phenotypes, including those already mentioned, became the central
focus of this study.
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Figure 4.9. D N A sequencing of phosphoglucomutase (pgm) and phosphoglucose isomerase (pgm)
operon from B. bronchiseptica BB7865. (A) Diagrammatic illustration of the D N A sequencing
strategy of p N W 2 4 the and primers employed. Primer sequences are listed in Appendix II. (B)
Nucleotide and deduced amino acid sequence of the P G M and P G I operons. A putative ShineDalgarno sequence (underlined) is located 4 base pairs upstream of the pgm methionine start codon
(bold). The pgm an&pgi genes are separated by only 10 base pairs. The pgi gene sequenced from B.
bronchiseptica and shown here is incomplete however sufficient data exists for adequate homology
alignment.
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The two genes P G M and P G I appear to be organised into an operon (Figure 4.10)

based on their spatial organisation and the absence of an intervening promotor-like

sequence. They are also found in a similar genetic organisation in B. pertussis wit
its PGM sharing 97% nucleotide sequence homology with that of B. bronchiseptica
(The Bordetella pertussis genome is found on line at
http://www.sanger.ac.uk/Projects/B_pertussis/). This operon has not been previously
described in the Genus Bordetella.

B. bronchiseptica
Phosphoglucomutase

Phosphoglucose
Isomerase

I—iiiiiiiiiiK B.

500 bp

pertussis

Galactosyl
transferase

Figure 4.10. Spatial orientation of the operon from B. bronchiseptica containing p g m and pgi.

The

equivalent genes were found to exist in B. pertussis in the same organisation and with high D N A
sequence homology (97%). The dashed line indicates the fragment of D N A cloned into p B B R l M C S 4 and thereafter utilised for complementation of BB7$65pgm.

Arrows indicate the direction of

transcription. Arrowheads indicate putative promotor sequences.

4.2.2. Alignment of the B. bronchiseptica PGM and PGI with other known
proteins

The predicted amino acid sequence of the B. bronchiseptica PGM protein was

pared to all proteins listed in the non-redundant protein database using the Blast

com
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algorithm. Five sequences which are most homologous to P G M were analysed using
the ClustalW alignment program. Results of this alignment are shown in Figure
4.11. The protein with highest amino acid sequence homology to the B.
bronchiseptica protein was that from B. pertussis at approximately 97% identity.
The exact identity or similarity percentages are unknown due to errors in the
published B. pertussis DNA sequence making correct amino acid predictions
impossible (Figure 4.11). The next closely aligned sequence to follow is the PGM
from Neisseria gonorrhoeae and Neisseria meningitidis, both with 55% identity and
72% similarity. Another protein demonstrating substantial homology was the PMM
of Pseudomonas aeruginosa, with approximately 55% identity and 73% similarity,
while others were the phosphomannomutase (PMM) of Azospirillum brasilense (42%
identity, 62% similarity) and PMM of Prochlorothrix hollondica (37% identity, 52%
similarity).

It is important to note that PGM is known to be a bifunctional enzyme (Sandlin and
Stein, 1994), capable of using either glucose or mannose as a substrate. Mannose

however is not reported as a component of the B. pertussis LPS (Allen et al, 1998a)

it therefore seems likely that the affected enzyme acts as PGM in both B. pertussis
and B. bronchiseptica and has henceforth been designated as such.
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Figure 4.11. ClustalW alignment of the deduced amino acid sequences from B. bronchiseptica
(Bbro) P G M with homologous sequences from other bacteria. Amino acids are expressed according
to the single letter code. Identical residues are depicted as dots (.), whereas differences are as shown.
To obtain the optimal alignment, gaps have been introduced into the sequence and are illustrated by
dashes (-).

The amino acid sequences that aligned most closely were those for P G M and

phosphomannomutase ( P M M ) from B. pertussis (putative PGM)(Bper), Neisseria meningitidis ( P G M )
(Nmen), Neisseria gonorrhoeae ( P G M ) (Ngon), Pseudomonas

aeruginosa ( P M M ) (Paer),

Azospirillum brasilense ( P M M ) (Abra), and Prochlorothrix hollondica ( P M M ) (Phol).

A n alignment of the deduced amino acid sequence of P G I was also carried out
(Figure 4.12). Although the pgi DNA sequence is incomplete, homology to PGI
from other species was consistently returned. B. pertussis possesses an ORF with

98% identity with the fragment of the B. bronchiseptica protein revealed thus far
Other organisms with homology are Zymomonas mobilis (36% identical), E. coli
(33.6% identical), Drosophila yakuba (32% identical), and Haemophilus influenzae
(32% identical).
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Figure 4.12. ClustalW alignment of the deduced amino acid sequences from the incomplete B.
bronchiseptica (Bbro) PGI with homologous PGI sequences for the equivalent region
species. Amino acids are expressed according to the single letter code. Identical

as dots (.), whereas differences are as shown. To obtain the optimal alignment, ga

introduced into the sequence and are illustrated by dashes (-). The amino acid seq

most closely to B. bronchiseptica (98%) was B. pertussis (Bper). Other species rep

Zymomonas mobilis (Zymo), Escherichia coli (Ecol), Drosophila yakuba (Dyak), and Hae
influenzae (Hinf).

4.2.2.1. Production of UDP-glucose and UDP-glucosamine
PGM and PGI are both required early in the pathway for production of sugar

nucleotides destined for LPS synthesis in other bacteria. In fact they both catalyse

the same substrate, glucose 1-phosphate, converting it to the respective precursors
(Figure 4.13).
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Glucose-6-phosphate

Fructose 6phosphate

Phosphoglucose
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Phosphoglucomutase

Glucose 1phosphate
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N-AcetylGlucosamine 6-phosphate

UTP-Glucose 1-phosphate
Uridyltransferase

UDP-GIucose

1
\

UDP-N-Acetyl-GIucosamine

L P S biosynthesis

Figure 4.13. Role of P G M and P G I in L P S biosynthesis. The probable pathway for the production of
the nucleotide sugars UDP-glucose and UDP-N-acetyl-glucosamine, shown as bold type, via P G M
and P G I (shown in red) respectively is illustrated. Modified from Zhou et al. (1994).

4.2.3. Production of the pgm mutation in a Bvg+ background

To allow for the effects of the pgm mutation to be observed in a 6vg-positive

background, the identical gene was mutated in BB7865, the wild type and pa
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strain of BB7866. This was achieved by w a y of an in vivo chromosome transfer
technique described previously (Smith and Walker, 1996) and as outlined here. The
procedure effected the transfer of the mini-transposon from BB7866pgra to the
homologous location on the wild type chromosome (BB7865/?gm). E. coli Q358
(pR715::Tno3/J) was mated with EB7S66pgm as described in "conjugation"
(experimental procedures) which resulted in the plasmid being introduced into
BB7866pgm. A permanent cointegration of the plasmid into the chromosome
occurred, catalysed by the transposase encoded by Tn813. This recombinant strain
of BB7866pgm (Tpr, Kmr) was then conjugally mated with BB7865 (Nalr, Rif1").
Chromosome transfer is promoted by the integrated tra genes of pR751 and the

recipient strain thus received the original Km cassette inserted into pgm followin
homologous recombination.

The resultant mutant was designated BB7865/?gm and a genetic map of the region in

question is illustrated in Figure 4.14A. Unequivocal evidence as to the presence o
the transposon can be seen in the Southern blot shown in Figure 4.15, where miniTn5 lacZl was utilised as probe, indicating a successful transfer to the BB7865^gm
genome.

Results

106

mini-Tn5 lacZl
EcoW
lacZ
Kanr
EcoYU

EcoRl
_f ""•""

* "" *

•

-—-•—•—

604 bp

572 bp

8.45 kb

B
1 2

3

4

5

6

7

8.4 kb
7.9 kb

Figure 4.14. Genetic characterisation of the pgm insertion mutation and the occurrence of pgm within
the Bordetella Genus. (A) Organisation of the mini-Tni lacZl insertion (5.0 kb). Transposition was
found to have occurred 604 bp downstream of the pgm methionine start codon. Also shown here is
the region amplified ( P C R 1) adjacent to the insertion site utilised for further Southern blot analysis.
(B) Identification of pgm in other Bordetella spp. The 300 by pgm P C R fragment (PCR-1), amplified
adjacent to the mini-Tn5 lacZl insertion from BB7866/?gm was used to probe the chromosomal D N A
of the Bordetella strains shown. The pgm gene exists in an EcoEl fragment of 8.4 kb. A n EcoRI site
located on the transposon results in a restriction fragment 539 bp shorter than that of the wild type
(Figure 4.14A), as shown.

Lane 1, BB7865; lane 2, BB7866; lane 3, BB7&65pgm;

BB7866>gw; lane 5, B. pertussis; lane 6, B. parapertussis; lane 7, B. avium.

lane 4,
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Figure 4.15. Southern blot of EcoKl digested chromosomal DNA utilising the mini-Tn5 lacZl as
probe to demonstrate the presence of the transposon and hence successful transfer of the pgm mutation
to BB7865pgm

(lane 3) from B B 7 8 6 6 p g w (lane 2). Wild type B B 7 8 6 5 was electrophoresed in lane 1.

There is a reduction of 539 bp in the EcoRl fragment due to the existence of an

EcoRI site in the transposon, as illustrated in Figure 4.14A and evident in the
Southern blot in Figure 4.14B. Of further interest, the PGM gene was shown via

Southern hybridisation, utilising the 300 bp PGM specific PCR product, to hybri
with DNA fragments of B. pertussis and B. parapertussis but not with B. avium
(Figure 4.14B). The respective growth rate of BB7S65pgm was not significantly
reduced as a result of the insertion mutation when compared to the wild type,

BB7865 (Figure 4.16). Motility of the recipient strain (BB7S65pgm) was tested in

order to ascertain whether similar phenotypes would accompany the genetic trans

Figure 4.17 illustrates that the transfer of the mini-Tn5 lacZl results in a re

motility as compared to the wild type, as was seen for BB7866pgm, the 6vg-negat
strain.
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Figure 4.16. Growth rates of BB7865, BB7865j9gw, BB7866, and BB7866pgm in SS-X at 37°C.
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Figure 4.17. Motility assay of BB7S65pgm as compared to BB7865 when cultured in modulating and

non-modulating conditions. Positions of strains included are depicted to the right

Results

4.2.4. Characterisation of the pgm

109

deficient phenotype

and its effect on

lipopolysaccharide biosynthesis.

Lipopolysaccharide can be described as a tertiary gene product, ie. one in which its
structure is fashioned by proteins (secondary gene products). The specificity of

enzymes in this process to affect both the synthesis, and the linkage together, of t
many components is an important principle. Failure to satisfactorily biosynthesise
attach any component of the molecule will result in the exclusion of the remaining
residues normally added subsequent to that point. PGM is an enzyme responsible for
the reversible conversion of glucose 6-phosphate to glucose 1-phosphate (Figure
4.13). This modification is an important step required early for inner core LPS
biosynthesis. Mutation of a gene responsible for such an enzyme would therefore be
expected to disrupt LPS biosynthesis.

4.2.4.1. Analysis of PGM enzyme activity of BB7865, BB7866 and the respective
mutants
Phosphoglucomutase activity assays were performed in order to determine the level
of enzyme activity in BB7865, BB7866, BB7865/?gm and BB7866pgm. These
assays demonstrate that the mutation eliminates the ability to produce functional
enzyme as BB7865/?gm and BB7S66pgm are shown to have PGM activity levels
below the detection limits of the assay (ie < 2 mU.mg"1). This was shown to be the
case for strains grown in either SS-C at 25°C and SS-X at 37°C (Figure 4.18).
Complementation of BB7S65pgm with the wild type pgm gene restored the specific
activity of PGM to levels equivalent to or higher than the wild type, as seen for
BB7S65pgm (pBBRlMCS-4/pgw+).
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BB7866

BBl$66pgm

BB7865

•

SS-C,25°C

•

SS-X, 37°C

BB7S65pgm BB7S65pgm
(pBBR\MCS-4/pgm+)

Strain

Figure 4.18. Specific activity of P G M (mU.mg" 1 ) from B. bronchiseptica wild type and mutant
strains, and the complemented mutant strain. Assays were conducted in triplicate for cells grown in
modulating and non-modulating conditions. Assays were performed with independent lysates on
three occasions. M e a n values are shown + standard error of the mean.

D u e to the fact that the mutated gene also shared high amino acid homology to P M M
of P. aeruginosa and others shown in Figure 4.11, phosphomannomutase activity
assays were conducted.

Activity levels for this enzyme were similar to those

obtained for P G M , with the mutants again displaying low levels of activity, as
compared to the wild type (Figure 4.19). Complementation of BB7S65pgm

with the

wild type pgm gene restored the specific activity of P M M to levels equivalent to or
higher than the wild type, as seen for BB7865/?gm (pBBRlMCS-4//?gm + ).
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Figure 4.19. Specific activity of P M M (mU.mg"1) from B. bronchiseptica wild type and mutant
strains, and the complemented mutant strain. Assays were conducted in triplicate for cells grown in
modulating and non-modulating conditions. Assays were performed with independent lysates on
three occasions. Mean values are shown + standard error of the mean.

4.2.4.2. lipopolysaccharide profiles of BB7865,

BB7866,

BB7865pgm

and

BB7866pgm.
Mutation of a gene regarded as being necessary for the biosynthesis of the foundation
of the L P S molecule would presumably have a significant impact on the resultant
overall structure.

Oxidative silver staining of electrophoretic profiles of L P S

extractions illustrate this point by clearly demonstrating the physical alterations
caused by the mutation of pgm (Figure 4.20). The band A and band B core structures
(Peppier, 1984), and the O-antigen are all seen to be present in the parental strains
(Figure 4.20, lanes 1, 2, and 6). However, O-antigen is absent from B B 7 8 6 5 p g m and
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B B 7 8 6 6 p g m and the core structure is considerably truncated, migrating faster than
the band B of the parental strains (Figure 4.20, lanes, 3, 4, 7, and 8).

The influence of the bvg locus on the expression of PGM was also analysed. At
37°C and in the absence of chemical modulators such as MgS04, an array of
virulence factors are expressed. A separate class of genes exist that are repressed
the bvg locus, including the genes encoding flagella biosynthesis (Akerley et al,
1992). This occurs with growth in modulating medium, ie. containing MgS04, at
lower temperatures (25°C). The Bvg locus has been reported to elicit some control
over the LPS of B. bronchiseptica. Testing the mutant strains in this way offers
some information as to the regulation of LPS biosynthesis. The size of the LPS
molecule from the mutant strains was unaffected by growth in either modulating or

non-modulating conditions. This is in contrast to the situation observed in the wild
type where production of Band B occurs only at 25°C and in roughly equal
proportions as Band A, the predominant LPS molecule of BB7865 at 37°C (Figure

4.20 lanes, 1 and 5). This may indicate that the bvg locus elicits control only over
the distal region of the molecule including the O-antigen.
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Figure 4.20. Electrophoretic profiles generated by T S D S - P A G E of L P S from B. bronchiseptica
BB7865, BB7866, BB7%65pgm,

and BB7866pgm. L P S extracted from each strain are illustrated as

follows: BB7865, lanes 1 and 5; BB7866, lanes 2 and 6; BB7865/?gw, lanes 3 and 7; and BB7866pg?w,
lanes 4 and 8. Strains represented in lanes 1-4 were cultured in SS-C at 25°C, whereas those shown in
lanes 5-8 were cultured in SS-X at 37°C. O-antigen and core band A and B are indicated to the left.

4.2.4.3. Complementation ofBB7865pgm

The possibility of pleiotrophic effects resulting from the transposition of the mi
Tn5 could not be discounted without successful complementation of the mutated

gene. The pgm gene DNA sequence data allowed for the construction of a restrictio

map, from which the identification of restriction sites flanking the gene was mad
possible. The restriction endonuclease Sacll was employed to release a 1.5 kb
fragment from pNW24, containing the complete pgm gene of BB7865 (Figure 4.10).
This fragment was cloned into the broad host range cloning vector, pBBRlMCS-4
(Kovach et al, 1995) and the resultant plasmid designated pBBRlMCS-4/pgm+. The
mini-Tn5 insertion into BB7S65pgm was subsequently complemented by the
conjugal transfer into BB7S65pgm of the plasmid pBBRlMCS-4/pgm+, which

harboured the 1.5 kb Sacll fragment. LPS was extracted from this strain after cul
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in both modulating and non-modulating conditions and electrophoresed via tricine
S D S P A G E to confirm the restoration of the wild type L P S phenotype (Figure 4.21).

In light of this result it can be concluded that mutation of the pgm from B.
bronchiseptica results in the observed phenotypic changes as complementation with
pgm from the parental B B 7 8 6 5 successfully restored the wild type L P S phenotype to
BB7865/?gm. The O-antigen and bands A and B are clearly visible in the L P S
extractions of the complemented strains (Figure 4.21 lanes 9 and 10).

Figure 4.21. Electrophoretic profiles generated by T S D S - P A G E of the complemented mutant strains
L P S as compared to the L P S of wild type strains and pgm mutant strains. The specific loading pattern
is as follows; BB7865, lanes 1 and 5; BB7866, lanes 2 and 6; BB7%65pgm,
BB7%66pgm,

lanes 3 and 7; and

lanes 4 and 8; Lanes 9 and 10 contain the complemented mutant, BB7865pgw

(pBBRlMCS-4//?gm + ).

Strains represented in lanes 1-4 and 10 were cultured in SS-C at 25°C,

whereas those shown in lanes 5-9 were cultured in SS-X at 37°C. O-antigen and core band A and B
are indicated to the left.
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RESULTS HI

5.1. The Behavioural Consequence of the/?gm Mutation

5.1.1. Chapter aims

Almost nothing is published regarding the influence LPS has during respiratory

infection by B. bronchiseptica. This is due in part to an absence of defined, viable,
LPS mutants. The aims of this chapter are to investigate the behavioural
characteristics of BB7865^gm in various in vitro assays that directly relate to the
survival ability of the mutant in vivo, such as resistance to oxidative stress, the

defensin cecropin P (an antimicrobial peptide), and invasion of epithelial cell lines.
An in vivo investigation of its capabilities to survive, cause infection, and elicit
immune response within the murine respiratory tract will then be determined.

5.1.2. Sensitivity of BB7865pgm and BB7866pgm to oxidative stress

Highly reactive oxygen anion radicals are an effective intracellular defence
mechanism employed by the host. Intracellular bacteria can utilise various enzymes
such as super oxide dismutase (SOD) for the conversion of these radicals to more

stable forms. Of interest here is the effect of a compromised physical barrier to fre
radical attack, therefore sensitivity of PGM mutants to oxidative stress was
measured. BB7865/?gm was notably more sensitive to paraquat (methyl viologen;
Sigma), a compound utilised to generate superoxide anion radicals. BB7S65pgm
exhibited a zone of inhibition of 8.5 mm on SS-C and 7 mm on SS-X at 37°C as
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compared to 0 m m for B B 7 8 6 5 at both conditions (Table 5.1). The strain
BB7S65pgm

(pBBRlMCS-4//?gm + ) shows that complementation of

BB7865pgm

with the wild type pgm gene restored the wild type phenotype, ie. resistance to
oxidative stress.

Table 5.1. Sensitivity of B. bronchiseptica to oxidative stress as measured by disk diffusion of
paraquat. M e a n values are shown for three separate assays ± standard error of the mean.

Zone of Inhibition ( m m )
Strain

30°C
SS-C

BB7866
BB7866pgw
BB7865
BB7%65pgm
BB7865pgm
(pBBRlMCS4/pgm+)

37°C
SS-X

SS-C

0+0

0±0

4.5 ±0.5
0+0
8.5 + 1.5

3.5 + 0.5

0+0
3.5 + 0.5
0+0
10.5 + 0.5

0±0

0±0
3+3
0+0

0±0

SS-X
0±0
1.5 + 1.5

0±0
7±0
0±0

5.1.3. Resistance to the cationic peptide cecropin P

LPS is credited as being responsible for conferring some protection against
antibiotics and serum ( W o o d et al, 1999) and is thus a m o d e of protection from host
defences. Another naturally occurring class of molecules are the "defensins". These
are cationic peptides found in a wide variety of vertebrate and invertebrate organisms
(Ganz and Lehrer, 1994) on the surface of skin, trachea, and tongue among others
(Harder et al, 1997; Schonwetter et al, 1995). Defensins are also encountered by
pathogens following engulfment by professional phagocytes and in the epithelial
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tissue of the upper respiratory tract (Falkow et al, 1992; Groisman, 1996).

The

sensitivity of BB7865pgm to the defensin cecropin P in a radial diffusion assay was
tested and shown to be significantly increased (P 0.01) as compared to the wild
type strain (Table 5.2). Complementation of BB7865/?gm with the wild type pgm
gene restored the wild type phenotype in radial diffusion assays. It was also
established that 90% of BB7865/?gm as compared to BB7865 cells were killed in a

liquid killing assay when incubated with a 100 pg.ml"1 solution of cecropin P for 1.5
h (Figure 5.1). These results, when considering the protection offered by LPS
against serum, lend further evidence to suggest that LPS constitutes a major
protective barrier to host defences.

Table 5.2. Sensitivity of B. bronchiseptica wild type and respective mutant strains
measured by radial diffusion. Inhibition zones refer to the diameter of the clear region surrounding
the point where the peptide was administered.

Zone of Inhibition

BB7866
BBl%66pgm
BB7865
BB7865/?gw
BB7865pgm (pBBR!MCS-4/pffm+)

11
17
11.3
16.3
106
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Figure 5.1. Susceptibility of BB7%65pgm

as compared to BB7865 to the action of cecropin P as

determined by liquid killing assays. Error bars indicate standard error of the mean as calculated from
triplicate experiments.

5.1.4. Superoxide dismutase activity of PGM deficient mutants

A higher susceptibility to oxidative stress m a y not only be attributed to a lack of L P S
but could stem from other pleiotrophic effects such as a depressed superoxide
dismutase (SOD) activity. SOD is a metalloenzyme that defends against the toxicity
of 02~ by catalysing the conversion of 02~ to H202 and H20 (Fridovich, 1978).
Resistance to these oxygen intermediates has been demonstrated as an important
survival strategy for several pathogens (Beaman and Beaman, 1984; Franzon et al,
1990; Tsolis et al, 1995). In order to test the possible connection between the
observed sensitivity to oxidative stress and a reduced SOD activity, SOD activity
assays were conducted. SOD activity levels remained unchanged for BB7865/?gm

(Figure 5.2) as compared to BB7865 signifying a role for LPS as a physical barrier.
The same trend was observed for BB7866 and the mutant BB7866/?gm. Other
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phenotypes tested that are suggested to participate in intracellular survival within
eukaryotic cells is acid phosphatase (Chhatwal et al, 1997).

Figure 5.2. Superoxide dismutase activity assay. Relative S O D activity is illustrated by the regions
not stained (white) by the nitro blue tetrazolium (dark background). Samples are depicted in the
following order. Lane 1, BB7865; lane 2, BB7866; lane 3, BB7865pgm; lane 4, BB7866/>gr«; lane 5,
BB7865; lane 6, BB7865/?gm.

5.1.5. Determination of acid phosphatase activity in P G M deficient mutants

Acid phosphatase is another enzyme that has been identified as being involved in
intracellular survival in m a n y pathogens (Rossolini et al, 1994; Satta et al, 1988),
including B. bronchiseptica (Chhatwal et al, 1997). This enzyme is thought to
inhibit the respiratory burst, thereby protecting the pathogen from host cell-generated
hydrogen peroxide and superoxide anions. Ineffective acid phosphatase function
could therefore be considered as a contributing factor to reduced intracellular
survival. T o investigate this, acid phosphatase activity assays were performed. The
level of acid phosphatase w a s indiscernible in the P G M deficient mutants as
compared to the parental strains (Figure 5.3), indicating the reduced ability to survive
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intracellularly, observed in B B 7 8 6 6 p g w and BB7865/?g7«, cannot be attributed to
insufficient acid phosphatase activity.

SS-XP, 37°C
1 2

3

SS-CP, 30°C

4

O
_^
i^.

Figure 5.3. Plate assay for acid phosphatase. Regions of blue indicate the presence of acid
phosphatase within the colony. Colony positions are: 1, BB7865; 2, BB7865ra (acid phosphatase
deficient mutant); 3, B B 7 8 6 6 ; 4, B B 7 8 6 6 r a (an acid phosphatase deficient mutant); 5, BB7865pgw;

6, BB7%66pgm.

5.1.6. In vitro intracellular survival of parental and pgm

deficient B.

bronchiseptica

In vitro invasion and survival of BB7865pgm and BB7866pgm were conducted in
direct comparison with BB7865 and BB7866. The J774.A1 mouse macrophage-like
cell line was utilised and demonstrated that the mutant strains possessed a
significantly reduced ability to survive. A s compared to the C F U of the respective
parental strains, only 4 0 % of BB7866pgm and 4 3 % BB7865/?gm remained after 24 h
(Figure 5.4). Initial invasion rates were also substantially lower compared to the
parental strains. After 2 h, BB7S65pgm

was reduced to 6 0 % C F U of BB7865 and

BB7866>gw was only 5 0 % C F U of parental. Assistance for this work was received
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from Heidi Jungnitz and Carlos G u z m a n of the National Centre for Biotechnology,
Germany.

o
s-
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U
o
U

BB7866

BB7866pgm

BB7865

•

2h

D

24 h

BB7865/?gw BB7865/?gro
(pBBRlMCS-4//?g7n+)

Strain
Figure 5.4. Intracellular survival of B. bronchiseptica strains in J774.A1 cells at 2 h and 2 4 h.
Results s h o w n are represented as m e a n percentages of C F U recovered of the respective parental
strains. Error bars indicate the standard error of the mean. Variation between the parental strains,
their mutant derivatives and the complemented mutant strain were considered significant at P0.05
(*)•

5.1.7. Survival ofBB7865pgm

within the murine respiratory tract

In vitro survival assays demonstrated a marked reduction in the ability of the pgm
mutant to invade or persist within J774.A1 cells (Figure 5.4). Also illustrated is the
increased susceptibility to oxidative stress and the antimicrobial peptide, Cecropin P.
Interestingly, all of the above phenotypic disturbances occur despite S O D and acid
phosphatase activities remaining unaffected.

O f major significance to our

understanding of B. bronchiseptica pathogenesis is the consequence of a deep L P S
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mutation on in vivo pathogenesis as determined using a murine respiratory infection
model.

Non-lethal doses of BB7865 or BB7865pgm were administered to BALB/c mice
intranasally and the numbers of CFU present in the lungs were measured at varying
time points following infection. Although the wild type strain showed a classic

pattern of infection (Jungnitz et al, 1998), the mutant strain was unable to survive,

being effectively cleared within 4 days. Mice infected with the wild type strain sti
had an average of 1000 CFU/lung persisting 35 days following inoculation (Figure
5.5).

5.1.7.1. Humoral response to BB 7865pgm
An immunological analysis was made of the response elicited by BB7865/?gm upon
intranasal infection of mice. This was performed in order to ascertain weather this
type of LPS mutant could be useful as a possible vector for live respiratory tract
vaccines. ELISA was used in order to evaluate several immunoglobulins and their

concentrations throughout the course of the infection. The antibodies tested for wer
IgG, IgM and IgA. Following infection of mice with BB7865/?gra, antibodies
specific for B. bronchiseptica BB7865 were not detected using ELISA analysis. In

contrast, B. bronchiseptica specific antibodies were detected following infection of
mice with wild type BB7865. The serum IgG profile is illustrated in Figure 5.6 as an
example of this point. Similar response profiles were obtained for IgM and IgA from
sera and lung wash respectively (results not shown).
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Figure 5.5. /« v/vo persistence of wild type BB7865 and the pgm mutant, BB7865/?g?w in a murine

respiratory model. Lungs were taken at different time intervals, and the number of viable bacte
lung were determined. The results are averages of values obtained for 4 mice.
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Figure 5.6. IgG response to BB7865 and BB7865pgm

respiratory infection

The average titre

returned from the sera of three individual mice is shown at each time point. A nominal value o
was chosen as the titre cut off.
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DISCUSSION

B. bronchiseptica is a respiratory pathogen of mammals of some significance. First,
due to the chronic nature of the infection observed in agricultural and veterinary

areas and secondly due to the close relationship it shares with B. pertussis. Much of
the information learnt of B. bronchiseptica is considered relevant to the
understanding of B. pertussis. Historically, research on these species has
concentrated almost exclusively on the wide array of the virulence determinants
produced by the bacterium that are of a proteinaceous nature. The ultimate goal of
such work has been the development of efficient vaccines and therapeutic
pharmaceuticals. Recently, more focus has been concentrated on lipopolysaccharide,
particularly concerning its structure and genetics of LPS biosynthetic enzymes.

LPS is a major component of the outer membrane of Gram-negative bacteria. It is
responsible for many biological effects during infection due to its endotoxic
qualities. However in Bordetellae, the contribution of LPS to protective immunity or
pathogenesis is not well understood (Gueirard et al, 1998). There has therefore been
considerable interest in the development of a "deep core mutant" (Allen et al,
1998b). One group described the deficiencies in our knowledge of the genetics of

the "deep parts of the molecule" as a constraint to our further understanding into th
role played by LPS (Makela and Stocker, 1984). In particular, researchers have been

interested in the structure and function of the outer membrane and its contribution t
pathogenesis. Until now, no information exists that address the above questions in
the Genus Bordetella.
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A mutation dramatically affecting the L P S of a bacterium, such is seen with
BB7S65pgm may very well have an indirect effect on other phenotypes, hence
pleotrophic effects are possible. One phenotype discussed here that may otherwise
make some contribution to colonisation is flagella. Our studies and those of Akerley
et al. (1992) have demonstrated that 6vg-positive B. bronchiseptica BB7865 is motile
at 37°C, albeit in the presence of modulating conditions. The same authors cite
preliminary results suggesting that an antibody response to flagellin accompanies
colonisation of guinea pigs by B. bronchiseptica (Akerley et al, 1992). Although
motility has recently been suggested only to play a role in the biology of B.
bronchiseptica during transmission between hosts (Akerley et al, 1995), it has also
been previously implicated in the pathogenic process. Mutation of the Salmonella
typhimurium gene flgM, the negative regulator of the flagellin-specific sigma factor
fliA, results in decreased ability to survive in macrophages and an attenuation of
virulence of the bacterium in mice (Schmitt et al, 1994). The ability of legionella
pneumophila to infect and multiply in human monocyte-like (U937) cells is related
to the expression of flagella. Also, insertional mutagenesis of L. pneumophila
resulted in 10 flagella negative strains of which 7 were unable to multiply
intracellularly within human U937 cells (Pruckler et al, 1995). Four non-motile
mutants of Vibrio cholerae required doses of at least 100 fold higher in order to
produce an infection in rabbits equivalent to that achieved by flagellated strains
(Yancey et al, 1978). Strains of frvg-positive B. bronchiseptica exhibit a motile
phenotype at 37°C under modulating conditions. Conditions in the animal host
where these environmental stimuli occur may include the initial stages of
colonisation and/or during intracellular survival within the host.
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T o characterise the role of flagella in eukaryotic cell invasion w e have examined the
ability of the non-motile mutants generated in this study to invade and survive in
eukaryotic cells. Although these particular cells may not be encountered by
Bordetella during infection, other cells of their type would be, ie. epithelial and
macrophage like cells. They therefore offer an excellent opportunity to study this
type of interaction in vitro. From the several motility mutants generated, different
survival abilities were obvious in vitro. The non-motile mutants AMM1 and AMM2
which did not express flagellin generally showed reduced ability to invade and
survive in HeLa cells, however only the measurement for AMM2 at 4 h showed a
significant decrease in % CFU recovered. On the other hand, although the nonmotile frvg-positive mutant VMM1 did not express flagellin it did demonstrate a
significant increase in the ability to invade and survive in HeLa cells as compared
with BB7865. The ability of the non-motile mutants to invade and survive in mouse

dendritic cells was also assessed to give a comparison with a different cell type, ie.
one with macrophage-like properties. Demonstrating a significantly reduced ability
to invade and survive in dendritic cells were AMM1 and VMM1 after 24 h.

The results described here have demonstrated that different non-motile insertion
mutations alter the ability of B. bronchiseptica to invade and survive in eukaryotic
cells. If motility were not involved at all in host colonisation one might have
expected non-motile mutants to behave in an identical manner to the motile parental

strains. The avirulent non-motile strains used in this study showed little variation i

growth curves (results not shown) indicating that values for invasion and survival are
not a function of differing growth rates due to, for example, genes responsible for
viability. Although the individual flagellation phenotype of the mutants during the
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assays were unknown, this does not detract from the results, which are, differing
motility capabilities lead to differences as seen in these assays.

A new gene cluster critically involved in the production of LPS in B. bronchiseptica
has been described here. This operon includes genes identified as
phosphoglucomutase and putative phosphoglucose isomerase, which are utilised in
the synthesis of nucleotide sugars for inclusion into growing LPS molecules. Of

further interest is the fact that the abolition of PGM activity renders the bacteria mo

susceptible to antimicrobial peptides and oxidative stress, reduces bacterial ability t
survive within J774.A1 cells, and results in an inability to colonise the murine
respiratory tract.

Originally, the pgm mutation described was thought to exist in a gene directly
responsible for flagella biosynthesis or function due to the fact that the resultant
strain, BB7866pgm (formally AMM4), displayed a motility phenotype incongruous
with that of the parental strain. The mutation has now been identified as one which
knocks out phosphoglucomutase activity and hence LPS production. BB7866pgm is
incapable of motility at higher growth temperatures of 37°C, although was found to
regain partial motility at 25 °C after growth in either modulating or non-modulating
media. These observations are complemented by the western blot analysis of
flagellin protein, which demonstrate that loss of motility in BB7866/?gm is not due to

a non-functioning flagella structure but the physical absence of it. It is not difficul
to appreciate that a degradation of the cellular membrane, as would occur due to a
deep LPS mutation, could result in the destabilisation of the very compartment in
which the flagella is anchored. Another possibility may be that a mutation of this
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type does not allow for the assembly of the flagella molecule. In this case the

flagella subunits may be transported directly into the extracellular environment. A
to why motility, though substantially reduced, is possible at lower growth

temperatures, the answer is only speculative. The LPS of B. bronchiseptica is known

to be influenced by growth temperature, often in a non-6vg related fashion (van den
Akker, 1998). This fact may account for the unusual finding of differential
expression of flagella from a mutant derived from a Z?vg-negative parental strain
(BB7866). The TSDS PAGE of the LPS profiles show the wild type, BB7865, as
having different LPS phenotypes when cultured in modulating and non-modulating
conditions. However there seems to be no significant difference in the size of the
truncated molecule between BB7865;?gm and BB7866/?gm, which might otherwise

imply a possible structural change which makes motility possible. This is not to sa
that there is no modification to the remaining LPS molecule by lower growth
temperature, just one that does not produce a mobility shift of LPS bands during
TSDS PAGE.

The role played by the bvg locus in regard to the regulation of the PGM operon was

investigated and was not found to be required for expression. As stated earlier, th
bvg locus has been shown in this study and in others (van den Akker, 1998) to
influence the expression of LPS in response to a modulating environment (ie.
reduced temperature and increased sulfate anions). This is exemplified by the
identical LPS profile of the 6vg-negative mutant BB7866 and wild type BB7865
grown in SS-C at 25°C compared to the contrasting LPS profiles seen in BB7865
when grown in SS-X at 37°C. It has also been observed that LPS expressed by B.
bronchiseptica can change during an infection (Gueirard et al, 1998). This type of
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expression has been suggested to be a mechanism of adaptation to the host
environment in other mucosal pathogens such as P. aeruginosa and N. gonorrhoeae
(Deretic et al, 1995; Van Putten, 1993). The length of the O-antigen has been
demonstrated to be an important factor for resistance to complement (Byrd et al,
1991). It is therefore feasible that the regulation of LPS composition includes one

form required for colonisation/invasion and another for survival in a particular nich
protected from host humoral defences. The 6vg-repressed form of LPS may also be
advantageous to the cell during transmission between hosts. Other evidence existing
for 6vg-regulated LPS expression includes monoclonal antibodies specific for band B
LPS of B. pertussis, which only react with B. bronchiseptica LPS in a frvg-repressed
state (Martin et al, 1992).

However, pgm is not regulated by bvg. There is not a significant difference in the
activity of the enzyme produced by frvg-positive or 6vg-negative parental strains
under any growth condition. This result is mirrored in the LPS profiles of the mutant

strains that indicate the same size LPS molecule is produced for both, irrespective o
growth conditions. A possible explanation for this observation is that the early core
biosynthesis is not 6vg-regulated. The Lipid A and KDO residues of the inner core
are known to be critical for the growth of E. coli (Kadrmas and Raetz, 1998),
whereas many of the core sugars and the O-antigen are not (Rietschel et al, 1994;
Kadrmas and Raetz, 1998; Makela and Stocker, 1984). Considering these facts,
genes associated with early core biosynthesis are likely to be expressed as
housekeeping genes rather than being controlled by the virulence regulator given
their importance to cell viability. Further, genes utilised for the synthesis of the
molecule distal to the core glucose are not required for growth but are utilised for
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virulence and thus m a y be regulated by the bvg locus. This hypothesis also seems
likely when considering that the genes of the PGM operon are distinct from the other
LPS biosynthesis genes, such as the wlb genetic locus responsible for band A
biosynthesis and also those involved in O-antigen production. The waaA and waaC
genes, two other genes required for synthesis of the deep inner core, are also not
incorporated within the wlb locus (Allen et al, 1998a; Preston et al, 1999).

In order to address the concern of pleotrophic effects of the pgm mutation which
might subsequently be responsible for various phenotypic changes, complementation
of the defective gene was performed. In all phenotypes tested the complemented
mutant was a restored to wild type conditions. These experiments demonstrated that
PGM of B. bronchiseptica is critically involved in the biosynthesis of LPS. This
work also demonstrated that the phenotypic changes observed in the mutants is likely
to be a factor of pgm alone and not a combination of pgm and pgi despite these two

genes being organised into an operon. The fact that there is no ribosome binding site
between the two genes and that plasmid pBBRlMCS-4/pgm contained only the pgm
gene (figure 4.10) in an extrachromosomal fashion, would tend to suggest that only
the pgm gene is utilised for the expression of the phenotypes tested.

The importance of LPS to pathogenesis can be inferred by the B. bronchiseptica pgm
mutant. The growth rate experiments of BB7865pgm demonstrate that lipid A and
the remaining LPS core molecule are sufficient for viability, however, data obtained

from the murine respiratory infection model clearly illustrate that this truncated f
of LPS is inadequate for colonisation and survival of B. bronchiseptica in vivo. The
absence of the O-antigen is likely to be a major factor in the behaviour of the
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mutant in vivo. The increased sensitivity to defensins for example, is

probably due to the lack of the O-antigen and may offer some reason as to why
bacterial clearance was so efficient.

The antimicrobial peptide tested in this study was of the cecropin class. These, like

the defensins, are cationic peptides and play an important role in the innate immunity

of the host respiratory tract. The mode of action of the peptides is the destabilisati
of the cellular membrane by binding with anionic phospholipids (Maloy and Kari,
1995). The O-antigen of B. bronchiseptica is thought to constitute a protective
barrier by concealing the negative charge of the membrane (Banemann et al, 1998).

LPS is known to be protective against complement attack and antibody deposition,
and also against opsonisation which facilitates phagocytosis. The LPS of Salmonella
typhimurium achieves this type of protection due to the long side chains. These
structures cause the complement to be deposited at a position sufficiently far enough
from the cellular membrane to avoid interaction between the two (Joiner et al,
1982). This information supports the theory of LPS forming a physical barrier which
shields the outer membrane from host defences.

An interesting hypothesis has been put forward which suggests that the LPS of some
species may offer protection to the bacteria by way of molecular mimicry. It is the
immunochemical similarity of the LPS epitopes with those of human
glycosphingolipid antigens that aids in the evasion of host immunity (Preston et al,

1996). If this were found to be true for B. bronchiseptica it may also help explain the
variation observed in O-antigen structure in response to different hosts. The bvg-
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regulation of the distal portion of the L P S molecule is in response to the environment

in which the bacteria finds itself. In terms of survival, it may be that the ability t
express an O-antigen of the correct length and composition to suit the impending
conditions is imperative. Sequential mutagenesis of the LPS molecule from the
distal end would be required to highlight which portion of the molecule is
specifically required for pathogenesis and hence assist in answering this question.

Resistance to superoxide anions is an important factor in terms of bacterial
intracellular survival. Evidence to suggest that LPS is in some way responsible for a

level of protection from intracellular superoxide radicals may come from the fact that
the mutants were more susceptible to paraquat despite superoxide dismutase (SOD)
and acid phosphatase effectively remaining at wild type levels. Again, the high
charge of B. bronchiseptica O-antigen may shield the cell from the destructive 02~
radicals, at least at the concentrations tested in this study.

The finding that there was no antibody response against BB7865/?gm in vivo can

most likely be attributed to the early clearance of the bacterium, which may be due to
any, if not all of the behavioural consequences of the mutation as already discussed.
BB7865jt>gm was not able to persist in vivo long enough for antigen processing, B

cell differentiation and proliferation to occur. This response (IgG) was first apparen
for BB7865 after 4 days but only became significant after 8 days, by which time no
CFU of BB7865/?gm remained. This finding may prevent the development of
BB7865/?gm, and probably any deep core mutants, as vaccine candidates.
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The L P S of B. bronchiseptica has emerged as a critical component of m a n y cellular
functions, not the least being pathogenesis. Functions attributed to this molecule in
B. bronchiseptica are many and varied, broadly including viability, colonisation,
invasion, host defence evasion, and finally in vivo survival. Attempting to
understand Bordetella pathogenesis and further vaccine or pharmaceutical
development requires consideration of LPS biosynthesis and function. Many more
qualities are sure to be attributed to the LPS of this species and the Genus Bordetella
in general and hence this extremely complex and interesting molecule warrants
further investigation.
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CONCLUSION

Lipopolysaccharide of Gram-negative bacteria is a major and vital component of the
cellular membrane. Hence LPS has been shown to play several key roles in the
virulence of several species. The LPS of Bordetella has only very recently become
the focus of experimentation. The recent discovery of a large genetic locus from B.
pertussis responsible for LPS biosynthesis has been followed by discovery of the
homologous locus in B. bronchiseptica. However, until now no work has attempted
to characterise the importance of LPS to Bordetella virulence. This study has
identified and provided the nucleotide sequence of a novel genetic locus involved in

the biosynthesis of core LPS in B. bronchiseptica. The gene of central interest to th
study, encoding phosphoglucomutase, catalyses an important step in the conversion
of glucose to the high energy nucleotide sugar, UDP-glucose for inclusion into the
core. Mutation of pgm results in a dramatically restricted LPS molecule devoid of
band A, band B and O-antigen.

A mutation resulting in the loss of the above structures renders the bacteria more
susceptible to its environment. Key deficiencies are an increased susceptibility to
oxidative stress, antimicrobial peptides, and a decreased ability to survive within
epithelial cells in vitro. The LPS deficient mutant was severely impaired in its
colonisation ability of the murine respiratory tract indicating a vital role for LPS
vivo. Complementation of the mutated pgm gene with that of the wild type restored
the O-antigen, band A, and band B to the LPS molecule. Also restored to the wild
type condition upon complementation was resistance to the antimicrobial peptide,
cecropin P and oxidative stress. Further, BB7865/?gm regained its ability to invade
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and survive in an eukaryotic cell line in vitro. In order to specify h o w m u c h of the
LPS molecule is required (for example O-antigen) by the cell for effective
pathogenesis, sequential mutations from the distal end of the molecule would need to
be undertaken.
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APPENDIX I

Growth Media and Solutions

Growth media

Bordet Gengou Medium (BG)

Bordet Gengou agar base

30g/L

Glycerol

lOg/L

Defibrinated horse blood

10%

Luria Bertani Medium (LB)

Tryptone
Yeast extract
NaCl

10g/L
5g/L
10g/L

Modified Cohen Wheeler Medium

Casamino acids

20g/L

Soluble starch

2g/L

L-Cystine

30mg/L

Nicotinic acid

5mg/L

KH2PO4

0.4 g/L

MgS04.7H20

40mg/L

FeS04.7H20

2mg/L

Yeast extract

3g/L

pH7.1

Stainer and Scholte Medium

SS-X and SS-C Salts (xlOO)
L-Cysteine
FeS04.7H20
Ascorbic acid

0.4 g/100ml
0.1 g/lOOml
0.2 g/100ml
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Nicotinic acid
Glutathione

40 mg/ 100ml
1 g/100ml

SS-XBase
Glutamic acid
L-Proline

10.72 g/L
0.24 g/L

NaCl

2.5 g/L

KH2PO4

0.5 g/L

KC1

0.2 g/L

MgCL2-6H20

0.1 g/L

CaCl2
Tris base
Agar technical

20mg/L
6.075 g/L
15 g/L

pH7.6

SS-C Base
Glutamic acid
L-Proline

10.72 g/L
0.24 g/L

MgS04.7H20

20 g/L

KH2PO4

0.5 g/L

KC1

0.2 g/L

MgCL2.6H20

0.1 g/L

CaCl2
Tris base
Agar technical

20mg/L
6.075 g/L
15 g/L

pH7.6

Z Medium
Glucose
CaCl2-2H20
NaCl
Tryptone
Yeast extract

lg/L
0.367 g/L
10 g/L
10 g/L
5g/L

158
Glycerol for Storage of Cells

Casamino acids

,0/
1 /o

Glycerol

1Q%

Chemically competent cells
Glycerol

5QO/o

General Buffers

PBS

NaCl

8g/L

KC1

0.2 g/L

Na2HP04

1.44 g/L

KH2P04

0.24 g/L

pH7.4

TE Buffer

Tris-HCl 10 mM
1mM

EDTA
pH8.0

Modified TE Buffer

Tris-HCl 10 mM
EDTA

25 m M

pH8.0

TES Buffer

Tris-HCl 10 mM
EDTA
NaCl

25

mM

0.15 M
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Tris Saline Buffer

1M Tris

50 ml/L

5MNaCl

100 ml/L

pH7.2
Gel electrophoresis Solutions

8x PAGE Running Buffer
Tris base 15 g/L
Glycine
SDS

72

&L

5

8/L

pH8.3
PAGE

Sample Buffer

Tris (pH 6.8)

60 m M

SDS

1%

p-Mercaptoethanol

1%

Glycerol
BPB

10%
0.01%

10% Acrylamide gels
Acrylamide 35%/bis-acrylamide 0.8% stock
TEMED

2.85 ml
50 ul
50

Ammonium persulfate, 1 0 % stock (freshly prepared)

^
100 ul

SDS 1 0 % stock
dH20

4.5 ml

1.5 Mtris-saline

2.5 ml

50xTAE Buffer
242 g/L
Tris base
Glacial acetic acid
0.5 M E D T A (pH 8.0)

57.1 ml/L
100 ml/L
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Agarose

gels

Agarose

g_.%

TAE
lx
Sequencing Gels-48 cm

Urea

28.8 g
Acrylamide (40%>)
Milli Q d H 2 0

3 5

T B E (filtered) 1 Ox

™

8 m]

TEMED

55 ul

APS

Sequencing

,

85

400 p.1

Loading

Buffer

Formamide (deionised) 5X
E D T A (25mM)/blue dextran (50 mg/ml)

1x

Silver Staining Solutions

Fixing Solution

Ethanol 40%
Acetic acid
Milli Q d H 2 0

5%
To 200 ml

Oxidising Buffer

Ethanol 40%
Acetic acid

5%

Periodic acid

0.7%

Milli Q d H 2 0

To 200 ml
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Staining Reagent

Ammonium hydroxide
NaOH(O.lM)

2 ml
28 ml

Silver nitrate (20%)
Milli Q d H 2 0

5 ml
To 150 ml

Development Solution

Citric acid

10m

8

Formaldehyde (37%)
Milli Q d H 2 0

10

°^

To 200 ml

Southern Hybridisation Solutions

20x SSC

Sodium citrate
Sodium chloride

88.2 g/L
175.3 g/L

pH7.0

Hybridisation buffer

EDTA
NaHP04

ImM
40 mM
7%

SDS

lMNaHP04
134 g/L
Na2HP04
4 ml/L
8 5 % H3PO4

STE buffer

Tris-HCl
EDTA
NaCl
pH8.0

10 mM
ImM
0.1M
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Washing solution 1 and 2

EDTA

1 mM
40 mM

NaHP04
SDS

5%

Washing solution 3 and 4

EDTA !

mM

NaHP0 4
SDS

40 m

M

lo/o

Pharmacia Biotech FlexiPrep Kit Solutions

Solution I
Tris-HCl (pH 7.5)

100 m M

EDTA

10 m M

RNase I

400 u.g/ml

Solution II
NaOH
SDS

1M
5.3%

Solution III
Potassium

3M

Acetate solution.

5M

Sephaglas FP
Sephaglas
Guanidine-HCl

7 M

Tris-HCl (pH 7.5)

50 m M

EDTA

10 mM
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Wash buffer
Tris-HCl (pH 7.5)

20 m M

EDTA

2 mM

NaCl

200 m M

EtOH

60%

Western Hybridisation Solutions

Blocking Solution

Low fat instant milk (Dutch Jug) 5%
PBS

xl

Western Transfer Buffer

Tris base 3.1 g/L
Glycine
Methanol

14.4 g/L
20%

pH8.3

Development Solution

Part A
30% H202

20 ul

H2O

30 ml

Part B
4-Chloro-l-napthol
Methanol

30m

§
10 ml

ELISA solutions

Coating Buffer

Methyl Glyoxal
PH8.0

0.3%
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Wash Buffer

PBS
xl
Tween 20
0.05-0.01%
BSA
0.1%
pH 7.2-8.0
Blocking solution

PBS
xl
TW6en2

° 0.05-0.1%

BSA

1%
Substrate preparation

0 P D

H2O2(30o/0)

0.4g/L citrate buffer
lMl/m]

Citrate buffer

Cltrate

Phosphate (pH 5.0) 0.1 M
Hydrogen peroxide 0.03%

0.05 M
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APPENDIX II

Primers for DNA Sequencing and PCR

Primer Identification

Sequence

Universal forward

5 '-GTAAAACGACGGCCAGT-3'

Universal reverse

5 '-AATGTGTCCTTTGTCGATACTGG-3'

P24FP1

5 '-TGATGCGCACTTCGAGCGCGTG-3'

P24FP2

5 '-GTGCTTATTCCTACGCCGCGC-3'

P24FP3

5 '-ACCGCCAGCTGATCCTGTTCG-3'

P24RM3

5' - ACCGCC AGCTG ATCCTGTTCG-3'

P24RM2

5 '-AAGCTGGAAATGGCCGAGGGC-3'

P24RM1

5' -C A G C AGGATTTCG AC AACGGC-3'

P24R

Universal Reverse

P24RP1

5 '-GTTGTCGAAATCCTGCTGCGC-3'

P24RP2

5 '-TCGCCCTCGGCCATTTCCAGC-3'

P24RP3

5 '-TGGCCCGACTTGGTCACCACG-3'

P19RP2

5 '-TCGGGATGGTGGTTGGGAAA-3'

P19RP3

5 '-TATCCACACCGCCTTCCATGA-3'

P27F

Universal Forward

PCR-1

5 '-ATGATCTGGCCGGACTTGGTCACC-3'
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